☰

Linda Liau, M.D., Ph.D. - Publications

Affiliations: 
Brain Research Institute, Neurological Surgery University of California, Los Angeles, Los Angeles, CA 
Area:
Anaplastic astrocytoma, ependymoma, ganglioma, GBM
Website:
http://faculty.bri.ucla.edu/institution/personnel?personnel_id=8887
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

105/374 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Everson RG, Hugo W, Sun L, Antonios J, Lee A, Ding L, Bu M, Khattab S, Chavez C, Billingslea-Yoon E, Salazar A, Ellingson BM, Cloughesy TF, Liau LM, Prins RM. Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients. Research Square. PMID 37790490 DOI: 10.21203/rs.3.rs-3287211/v1  0.729
2023 Sun L, Kienzler JC, Reynoso JG, Lee A, Shiuan E, Li S, Kim J, Ding L, Monteleone AJ, Owens GC, Phillips JJ, Everson RG, Nathanson D, Cloughesy TF, Li G, ... Liau LM, et al. Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors. The Journal of Clinical Investigation. 133. PMID 37655659 DOI: 10.1172/JCI169314  0.398
2023 de Godoy LL, Chawla S, Brem S, Wang S, O'Rourke DM, Nasrallah MP, Desai A, Loevner LA, Liau LM, Mohan S. Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model. Journal of Neuro-Oncology. PMID 37129737 DOI: 10.1007/s11060-023-04324-4  0.309
2022 Liau LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, Tran DD, Ansstas G, Cobbs CS, Heth JA, Salacz ME, D'Andre S, Aiken RD, Moshel YA, Nam JY, et al. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. Jama Oncology. PMID 36394838 DOI: 10.1001/jamaoncol.2022.5370  0.31
2022 Ghochani Y, Muthukrishnan SD, Sohrabi A, Kawaguchi R, Condro MC, Bastola S, Gao F, Qin Y, Mottahedeh J, Iruela-Arispe ML, Rao N, Laks DR, Liau LM, Mathern GW, Goldman SA, et al. A molecular interactome of the glioblastoma perivascular niche reveals integrin binding sialoprotein as a mediator of tumor cell migration. Cell Reports. 41: 111511. PMID 36261010 DOI: 10.1016/j.celrep.2022.111511  0.314
2021 Lee AH, Sun L, Mochizuki AY, Reynoso JG, Orpilla J, Chow F, Kienzler JC, Everson RG, Nathanson DA, Bensinger SJ, Liau LM, Cloughesy T, Hugo W, Prins RM. Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma. Nature Communications. 12: 6938. PMID 34836966 DOI: 10.1038/s41467-021-26940-2  0.35
2021 He L, Bhat K, Ioannidis A, Zhang L, Nguyen NT, Allen JE, Nghiemphu PL, Cloughesy TF, Liau LM, Kornblum HI, Pajonk F. Effects of the DRD2/3 Antagonist ONC201 and Radiation in Glioblastoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 34097975 DOI: 10.1016/j.radonc.2021.05.027  0.304
2021 Lee J, Uy BR, Liau LM. Brain Tumor Vaccines. Neurosurgery Clinics of North America. 32: 225-234. PMID 33781504 DOI: 10.1016/j.nec.2021.01.003  0.405
2020 Chuntova P, Chow F, Watchmaker P, Galvez M, Heimberger AB, Newell EW, Diaz A, DePinho RA, Li MO, Wherry EJ, Mitchell D, Terabe M, Wainwright DA, Berzofsky JA, Herold-Mende C, ... ... Liau LM, et al. Unique challenges for glioblastoma immunotherapy - Discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Neuro-Oncology. PMID 33367885 DOI: 10.1093/neuonc/noaa277  0.332
2019 Liu F, Cox CD, Chowdhury R, Dovek L, Nguyen H, Li T, Li S, Ozer B, Chou A, Nguyen N, Wei B, Antonios J, Soto H, Kornblum H, Liau L, et al. SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation. Journal of Neuro-Oncology. PMID 30838489 DOI: 10.1007/S11060-019-03126-X  0.681
2019 Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, ... ... Liau LM, et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nature Medicine. PMID 30742122 DOI: 10.1038/S41591-018-0337-7  0.377
2019 Yao J, Nathanson D, Yong WH, Salamon N, Lai A, Leia Nghiemphu P, Prins R, Pope W, Czernin J, Everson R, Liau L, Cloughesy T, Ellingson B. NIMG-60. IDH MUTANT GLIOMAS WITH 1p/19q CO-DELETION ARE LESS ACIDIC THAN NON-CO-DELETED GLIOMAS AS MEASURED WITH PH-WEIGHTED AMINE CEST-MRI AND AMINO ACID PET Neuro-Oncology. 21: vi174-vi175. DOI: 10.1093/Neuonc/Noz175.729  0.333
2019 Sun M, Orpilla J, Contreras E, Treger J, Molaie D, Tsang J, Antonios J, Wang A, Liau L, Prins R, Everson R. IMMU-50. SYSTEMIC ADOPTIVE TRANSFER IMMUNOTHERAPY WITH TCR-TRANSDUCED T-CELLS TARGETING NY-ESO-1 FOR MENINGIOMA Neuro-Oncology. 21: vi129-vi130. DOI: 10.1093/Neuonc/Noz175.542  0.688
2019 Kienzler J, Reynoso J, Owens G, Orpilla J, Lee A, Mochizuki A, Yong WH, Liau L, Prins R. IMMU-33. IMMUNE PROFILING REVEALS INHIBITORY MACROPHAGES AND A DISTINCT SPATIAL DISTRIBUTION OF IMMUNE CELLS IN DIFFERENT TYPES OF BRAIN METASTASES Neuro-Oncology. 21: vi126-vi126. DOI: 10.1093/Neuonc/Noz175.525  0.35
2019 Lee A, Pan Y, Mochizuki A, Galvez M, Chow F, Nathanson D, Wang A, Everson R, Liau L, Xing Y, Prins R. IMMU-02. NEOANTIGENS ARISING FROM ALTERNATIVE SPLICING EVENTS MAY BE TARGETED BY TUMOR INFILTRATING LYMPHOCYTES IN GLIOBLASTOMAS Neuro-Oncology. 21: vi118-vi119. DOI: 10.1093/Neuonc/Noz175.496  0.408
2019 Fernandez E, Mai W, Bayley N, Liau L, Cloughesy T, Letai A, Nathanson D. CBMT-44. COMPREHENSIVE CHARACTERIZATION OF THE INTRINSIC APOPTOTIC MACHINERY REVEALS THE MOLECULAR BLOCKS RESPONSIBLE FOR RESISTANCE TO CELL DEATH IN GLIOBLASTOMA Neuro-Oncology. 21: vi42-vi42. DOI: 10.1093/Neuonc/Noz175.166  0.403
2019 Morrow D, Bayley N, Williams K, Muranaka H, Prins R, Liau L, Cloughesy T, Bensinger S, Nathanson D. CBMT-43. INTEGRATED LIPIDOMIC AND MOLECULAR ANALYSIS REVEALS A SUBSET OF GLIOBLASTOMA VULNERABLE TO FERROPTOSIS Neuro-Oncology. 21: vi42-vi42. DOI: 10.1093/Neuonc/Noz175.165  0.328
2019 Bayley N, Tse C, Baufeld L, Gosa L, Yan W, Zhu H, Balanis N, Cloughesy T, Liau L, Graeber T, Nathanson D. TMIC-26. PRECLINICAL MODEL SYSTEMS OF GLIOBLASTOMA REVEAL MICROENVIRONMENTAL PROGRAMS AND DEPENDENCIES IN PATIENT TUMORS Neuro-Oncology. 21: vi253-vi253. DOI: 10.1093/Neuonc/Noz175.1060  0.441
2019 Mochizuki A, Lee A, Orpilla J, Kienzler J, Galvez M, Chow F, Davidson T, Wang A, Everson R, Liau L, Cloughesy T, Prins R. TMIC-06. MYELOID POPULATIONS AND THE EFFECT OF NEOADJUVANT PD-1 INHIBITION IN THE GLIOBLASTOMA MICROENVIRONMENT: A SURFACEOMIC AND TRANSCRIPTOMIC DISSECTION AT THE SINGLE-CELL LEVEL Neuro-Oncology. 21: vi248-vi248. DOI: 10.1093/Neuonc/Noz175.1040  0.481
2019 Chow F, Mochizuki A, Lee A, Galvez M, Orpilla J, Everson R, Liau L, Cloughesy T, Prins R. ATIM-16. VALIDATION OF RESPONSE TO NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY IN RECURRENT GLIOBLASTOMA Neuro-Oncology. 21: vi4-vi5. DOI: 10.1093/Neuonc/Noz175.016  0.425
2018 Davidson TB, Lee AH, Hsu M, Sedighim S, Orpilla J, Treger J, Mastall M, Roesch S, Rapp C, Galvez M, Mochizuki AY, Antonios JP, Garcia AJ, Kotecha N, Bayless NL, ... ... Liau LM, et al. Expression of PD-1 by T cells in malignant glioma patients reflects exhaustion and activation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30498094 DOI: 10.1158/1078-0432.Ccr-18-1176  0.692
2018 Everson RG, Antonios JP, Liau LM. Cell-Based Immunotherapy of Gliomas. Progress in Neurological Surgery. 32: 90-100. PMID 29990977 DOI: 10.1159/000469683  0.721
2018 Cloughesy TF, Landolfi J, Vogelbaum MA, Ostertag D, Elder JB, Bloomfield S, Carter B, Chen CC, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu P, et al. Durable Complete Responses in Some Recurrent High Grade Glioma Patients Treated with Toca 511 & Toca FC. Neuro-Oncology. PMID 29762717 DOI: 10.1093/Neuonc/Noy075  0.345
2018 Cloughesy TF, Landolfi J, Vogelbaum M, Ostertag D, Elder B, Carter B, Chen CC, Kalkanis S, Kesari S, Lai A, Lee I, Liau L, Mikkelsen T, Nghiemphu L, Piccioni D, et al. Abstract A085: Durable responses observed in recurrent high-grade glioma (rHGG) with Toca 511 and Toca FC treatment Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A085  0.449
2018 Antonios JP, Soto H, Everson RG, Wang AC, Bethel J, Radu C, Ellingson B, Phelps M, Cloughesy TF, Prins RM, Liau LM. 214 Noninvasive Monitoring of Immunotherapeutic Responses in Glioblastoma Using Novel Imaging Techniques Neurosurgery. 65: 120-120. DOI: 10.1093/Neuros/Nyy303.214  0.634
2018 Bethel J, Aliche J, Orpilla J, Soto H, Everson R, Davidson T, Wang A, Liau L, Prins R. IMMU-37. VEMURAFENIB ENHANCES THE CYTOTOXICITY OF NY-ESO-1 TCR ENGINEERED T-CELLS FOR BRAF MUTANT BRAIN TUMORS Neuro-Oncology. 20: vi129-vi129. DOI: 10.1093/Neuonc/Noy148.540  0.397
2018 Mochizuki A, Orpilla J, Lee A, Garcia A, Liau L, Cloughesy T, Prins R. IMMU-28. HIGH-DIMENSIONAL SINGLE CELL CHARACTERIZATION OF THE SYSTEMIC INFLUENCE OF NEOADJUVANT PD-1 BLOCKADE IN PATIENTS WITH RECURRENT GLIOBLASTOMA Neuro-Oncology. 20: vi127-vi127. DOI: 10.1093/Neuonc/Noy148.531  0.315
2018 Lee A, Mochizuki A, Ishihara M, Garcia A, Nathanson D, Wang A, Everson R, Liau L, Prins R. IMMU-21. MULTIDIMENSIONAL CHARACTERIZATION OF IMMUNE CELL POPULATIONS IN THE GLIOMA TUMOR MICROENVIRONMENT REVEALS A DOMINANT PROPORTION OF CELLS DERIVED FROM THE MYELO-MONOCYTIC LINEAGE Neuro-Oncology. 20: vi125-vi125. DOI: 10.1093/Neuonc/Noy148.524  0.468
2018 Bayley N, Baufeld L, Gosa L, Morrow D, Tse C, Balanis N, Yan W, Cloughesy T, Liau L, Graeber T, Nathanson D. TMOD-03. GLIOMAPDOX: A MOLECULARLY DIVERSE LIBRARY OF DIRECT-FROM-PATIENT ORTHOTOPIC GLIOMA XENOGRAFTS RECAPITULATES INTRATUMOR HETEROGENEITY Neuro-Oncology. 20: vi268-vi269. DOI: 10.1093/Neuonc/Noy148.1116  0.316
2018 Antonios J, Everson R, Soto H, Khattab S, Bethel J, Sun M, Mochizuki A, Lee A, Odesa S, Billingslea-Yoon E, Moughon D, Wang A, Cloughesy T, Prins R, Liau L. ATIM-39. IMPROVED SURVIVAL NOTED IN GLIOBLASTOMA PATIENTS TREATED WITH ADJUVANT TLR-3 AGONIST IN SETTING OF AUTOLOGOUS LYSATE-PULSED DC VACCINATION Neuro-Oncology. 20: vi10-vi10. DOI: 10.1093/Neuonc/Noy148.034  0.692
2018 Orpilla J, Mochizuki A, Reynoso J, Akkad N, Lee A, Davidson T, Liau L, Cloughesy T, Prins R. ATIM-25. NEOADJUVANT PD-1 ANTIBODY BLOCKADE IS ASSOCIATED WITH FOCAL UPREGULATION OF PD-L1 AND CD8 T CELL INFILTRATE IN RECURRENT GLIOBLASTOMA Neuro-Oncology. 20: vi6-vi6. DOI: 10.1093/Neuonc/Noy148.020  0.305
2018 Prins R, Mochizuki A, Orpilla J, Lee A, Davidson T, Gaffey S, Sanders C, Rytlewski J, Ellingson B, Li G, Yong W, Clarke J, Arrillaga-Romany I, Colman H, Reardon D, ... ... Liau L, et al. ATIM-12. NEOADJUVANT ANTI-PD-1 IMMUNOTHERAPY PROMOTES INTRATUMORAL AND SYSTEMIC IMMUNE RESPONSES IN RECURRENT GLIOBLASTOMA: AN IVY CONSORTIUM TRIAL Neuro-Oncology. 20: vi3-vi3. DOI: 10.1093/Neuonc/Noy148.007  0.366
2018 Mikkelsen T, Cloughesy T, Landolfi J, Vogelbaum M, Ostertag D, Elder J, Chen C, Kalkanis S, Kesari S, Lai A, Lee I, Liau L, Nghiemphu P, Piccioni D, Accomando W, et al. 25 Durable complete responses observed in patients with recurrent high grade glioma treated with Toca 511 & Toca FC Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 45: S11-S11. DOI: 10.1017/Cjn.2018.290  0.456
2017 Antonios JP, Soto H, Everson RG, Moughon DL, Wang AC, Orpilla J, Radu C, Ellingson BM, Lee JT, Cloughesy T, Phelps ME, Czernin J, Liau LM, Prins RM. Detection of immune responses after immunotherapy in glioblastoma using PET and MRI. Proceedings of the National Academy of Sciences of the United States of America. PMID 28874539 DOI: 10.1073/Pnas.1706689114  0.713
2017 Antonios JP, Soto H, Everson RG, Moughon D, Orpilla JR, Shin NP, Sedighim S, Treger J, Odesa S, Tucker A, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM. Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma. Neuro-Oncology. PMID 28115578 DOI: 10.1093/Neuonc/Now287  0.742
2017 Cloughesy TF, Ostertag D, Landolfi JC, Walbert T, Vogelbaum MA, Elder JB, Bloomfield S, Carter B, Chen C, Kalkanis SN, Kesari S, Lai A, Lee I, Liau LM, Mikkelsen T, et al. Durable complete responses observed in IDH1 mutated high grade glioma at first recurrence undergoing treatment with Toca 511 and Toca FC. Journal of Clinical Oncology. 35: e13504-e13504. DOI: 10.1200/Jco.2017.35.15_Suppl.E13504  0.313
2017 Soto H, Antonios J, Everson R, Moughon D, Wang A, Orpilla J, Radu C, Ellingson B, Lee J, Cloughesy T, Phelps M, Czernin J, Liau L, Prins R. NIMG-36. DELINEATION OF IMMUNE RESPONSES AFTER IMMUNOTHERAPY IN GLIOBLASTOMA USING PET AND MRI Neuro-Oncology. 19: vi149-vi150. DOI: 10.1093/Neuonc/Nox168.611  0.694
2017 Lee A, Davidson T, Galvez M, Nathanson D, Wang A, Liau L, Prins R. IMMU-20. CHARACTERIZING THE IMMUNE LANDSCAPE OF PD-1/PD-L1 IN BRAIN TUMOR IMMUNE CELL POPULATION USING CyTOF MASS CyTOMETRY Neuro-Oncology. 19: vi116-vi116. DOI: 10.1093/Neuonc/Nox168.478  0.402
2017 Walbert T, Bota D, Vogelbaum M, Kalkanis S, Liau L, Mikkelsen T, Gruber H, Shorr J, Rodriguez-Aquirre M, Ostertag D, Mitchell L, Jolly D, Cloughesy T. ATIM-21. INTRAVENOUS DELIVERY OF TOCA 511 IN PATIENTS WITH HIGH GRADE GLIOMA RESULTS IN QUANTIFIABLE EXPRESSION OF CYTOSINE DEAMINASE IN TUMOR TISSUE Neuro-Oncology. 19: vi30-vi31. DOI: 10.1093/Neuonc/Nox168.116  0.402
2017 Walbert T, Bota D, Vogelbaum M, Kalkanis S, Liau L, Mikkelsen T, Gruber H, Shorr J, Rodriguez-Aguirre M, Ostertag D, Mitchell L, Jolly D, Cloughesy T. SCDT-06. QUANTIFIABLE LEVELS OF THE TRANSGENE, CYTOSINE DEAMINASE, IN TUMOR SAMPLES FOLLOWING INTRAVENOUS DELIVERY OF TOCA 511 IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA Neuro-Oncology. 19: vi265-vi266. DOI: 10.1093/Neuonc/Nox168.1089  0.395
2016 Antonios JP, Soto H, Everson RG, Orpilla J, Moughon D, Shin N, Sedighim S, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM. PD-1 blockade enhances the vaccination-induced immune response in glioma. Jci Insight. 1. PMID 27453950 DOI: 10.1172/Jci.Insight.87059  0.725
2016 Hsu M, Sedighim S, Wang T, Antonios JP, Everson RG, Tucker AM, Du L, Emerson R, Yusko E, Sanders C, Robins H, Yong WH, Davidson TB, Li G, Liau LM, et al. TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination. Cancer Immunology Research. PMID 26968205 DOI: 10.1158/2326-6066.Cir-15-0240  0.745
2016 Antonios J, Soto H, Everson R, Orpilla J, Shin N, Moughon D, Sedighim S, Treger J, Odesa S, Tucker A, Yong W, Cloughesy T, Prins R, Liau L. TMIC-16. TUMOR-INFILTRATING MYELOID CELLS MEDIATE ADAPTIVE IMMUNE RESISTANCE IN GLIOBLASTOMA Neuro-Oncology. 18: vi203-vi203. DOI: 10.1093/Neuonc/Now212.856  0.733
2016 Everson R, Shin N, Antonios J, Soto H, Tucker A, Zaretsky J, Orpilla J, Rathe S, Popescu F, Largaespada D, Liau L, Prins R. IMST-56. TUMOR LYSATE-PULSED DC VACCINATION INDUCES NEOANTIGEN-SPECIFIC T CELL RESPONSES Neuro-Oncology. 18: vi99-vi99. DOI: 10.1093/Neuonc/Now212.412  0.742
2016 Antonios J, Soto H, Everson R, Orpilla J, Shin N, Nathanson D, Harris R, Sadeghi S, Ellingson B, Liau L, Prins R. IMST-28. NON-INVASIVE IMMUNE MONITORING FOLLOWING DC VACCINATION EFFECTIVELY DELINEATES IMMUNE RESPONSES IN GLIOBLASTOMA Neuro-Oncology. 18: vi92-vi92. DOI: 10.1093/Neuonc/Now212.384  0.714
2016 Moughon D, Everson R, Odesa S, Soto H, Billingslea-Yoon E, Sedighim S, Orpilla J, Lin J, Prins R, Liau L. ATIM-32. PHASE IIA CLINICAL TRIAL EVALUATING DENDRITIC CELL VACCINE FOR THE TREATMENT OF LOW-GRADE GLIOMAS Neuro-Oncology. 18: vi25-vi25. DOI: 10.1093/Neuonc/Now212.097  0.363
2016 Davidson T, Hsu M, Sedighim S, Moughon D, Yong W, Liau L, Prins R. ATIM-26. PD-1 EXPRESSION BY TUMOR INFILTRATING LYMPHOCYTES IN GLIOBLASTOMA IS A MARKER OF BOTH ACTIVATION AND EXHAUSTION Neuro-Oncology. 18: vi23-vi23. DOI: 10.1093/Neuonc/Now212.091  0.393
2015 Reardon DA, Gilbert MR, Wick W, Liau L. Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy. Neuro-Oncology. 17: vii32-vii40. PMID 26516225 DOI: 10.1093/Neuonc/Nov178  0.399
2015 Everson RG, Antonios JP, Lisiero DN, Soto H, Scharnweber R, Garrett MC, Yong WH, Li N, Li G, Kruse CA, Liau LM, Prins RM. Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma. Neuro-Oncology. PMID 26330563 DOI: 10.1093/Neuonc/Nov153  0.702
2015 Harris RJ, Cloughesy TF, Liau LM, Prins RM, Antonios JP, Li D, Yong WH, Pope WB, Lai A, Nghiemphu PL, Ellingson BM. pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI. Neuro-Oncology. PMID 26113557 DOI: 10.1093/Neuonc/Nov106  0.62
2015 Antonios JP, Everson RG, Liau LM. Dendritic cell immunotherapy for brain tumors. Journal of Neuro-Oncology. 123: 425-32. PMID 26037466 DOI: 10.1007/S11060-015-1830-1  0.732
2015 Antonios J, Soto H, Orpilla J, Shin N, Everson R, Liau L, Prins R. Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P393  0.768
2015 Bosch M, Prins R, Liau L. Abstract 2491: Treatment with tumor lysate-pulsed autologous dendritic cells prolongs survival in patients with recurrent glioblastoma multiforme Cancer Research. 75: 2491-2491. DOI: 10.1158/1538-7445.Am2015-2491  0.401
2015 Antonios J, Soto H, Orpilla J, Shin N, Everson R, Liau L, Prins R. TMIC-04THERAPEUTIC ANTI-GLIOMA IMMUNITY IS DEPENDENT ON VACCINATION-INDUCED T CELL RESPONSES AND INHIBITION OF iAPC FUNCTION IN THE TUMOR MICROENVIRONMENT Neuro-Oncology. 17: v214.8-v215. DOI: 10.1093/Neuonc/Nov236.04  0.754
2015 Pelargos P, Qin Y, Voth B, Thill K, Chung L, Prins R, Liau L, Ung N, Hojat S, Yong W, Gordon L, Wadehra M, Yang I. MPTH-27A LARGE-SCALE UCLA GLIOMA TISSUE MICROARRAY IDENTIFIES EMP2 AS A NOVEL BIOMARKER FOR GBM THAT CORRELATES WITH OVERALL PROGNOSIS Neuro-Oncology. 17: v144.2-v144. DOI: 10.1093/Neuonc/Nov222.27  0.378
2015 Sedighim S, Hsu M, Antonios J, Emerson R, Yusko E, Sanders C, Davidson T, Liau L, Prins R. IMCT-11NEXT GENERATION T CELL RECEPTOR SEQUENCING CAN IDENTIFY, QUANTIFY, AND TRACK TUMOR-SPECIFIC T CELL POPULATIONS BEFORE AND AFTER DENDRITIC CELL VACCINATION IN GLIOBLASTOMA MULTIFORME PATIENTS Neuro-Oncology. 17: v109.4-v110. DOI: 10.1093/Neuonc/Nov218.11  0.757
2015 Hickey M, Soto H, Treger J, Erickson K, Malone C, Ha E, Young E, Prins R, Liau L, Kruse C. IMCT-10A PHASE I DOSE ESCALATION STUDY TO TEST THE SAFETY OF INTRATUMORAL ADOPTIVE IMMUNE THERAPY WITH AlloCTL IN RECURRENT GLIOMA PATIENTS Neuro-Oncology. 17: v109.3-v109. DOI: 10.1093/Neuonc/Nov218.10  0.39
2015 Kato Y, Scharnweber R, Inagaki A, Kamijima S, Hickey M, Lisiero D, Hermann K, Soto H, Antonios J, Sedighim S, Okada H, Liau L, Klatzmann D, Prins R, Kashara N. IMPS-19RETROVIRAL REPLICATING VECTOR-MEDIATED DELIVERY OF AN IMMUNODOMINANT NEO-ANTIGEN EPITOPE TARGET FOR VIRO-IMMUNOTHERAPY IN EXPERIMENTAL GLIOMA Neuro-Oncology. 17: v117.2-v117. DOI: 10.1093/Neuonc/Nov217.19  0.719
2015 Pelargos P, Qin Y, Voth B, Thill K, Chung L, Prins R, Liau L, Ung N, Hojat S, Yong W, Gordon L, Wadehra M, Yang I. ATPS-62TARGETING OF NOVEL GBM BIOMARKER EMP2 RESULTS IN DECREASED TUMOR GROWTH AND INCREASED TUMOR NECROSIS Neuro-Oncology. 17: v31.5-v32. DOI: 10.1093/Neuonc/Nov204.62  0.426
2014 Lisiero DN, Soto H, Everson RG, Liau LM, Prins RM. The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells. Journal For Immunotherapy of Cancer. 2: 8. PMID 25054063 DOI: 10.1186/2051-1426-2-8  0.333
2014 Everson RG, Jin RM, Wang X, Safaee M, Scharnweber R, Lisiero DN, Soto H, Liau LM, Prins RM. Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients. Journal For Immunotherapy of Cancer. 2: 10. PMID 24883189 DOI: 10.1186/2051-1426-2-10  0.364
2014 Kruse C, Liau L, Prins R, Antonios J, Ha E, Kasahara N, Soto H, Yang I. Chronic inflammation drives glioma growth: cellular and molecular factors responsible for an immunosuppressive microenvironment Neuroimmunology and Neuroinflammation. 1: 66. DOI: 10.4103/2347-8659.139717  0.722
2014 Garrett MC, Mottahedeh J, Sperry J, Eskin A, Coppola G, Shih Y, Lai A, Chou A, Liau L, Prins R, Cloughesy T, Wu H, Nelson S, Kornblum H. Abstract 447: The IDH1 mutation in human glioblastoma and its effects on epigenetic modification and cell fate selection Cancer Research. 74: 447-447. DOI: 10.1158/1538-7445.Am2014-447  0.369
2014 Hardy A, Prins R, Kong X, Woodworth D, Pope W, Yong W, Cloughesy T, Liau L, Ellingson B. NI-32 * ENHANCING TUMOR RESPONSE USING QUANTITATIVE VOLUMETRY FROM T1 SUBTRACTION MAPS IN MALIGNANT GLIOMA TREATED WITH DENDRITIC CELL VACCINATION Neuro-Oncology. 16: v145-v145. DOI: 10.1093/Neuonc/Nou264.30  0.491
2014 Antonios J, Soto H, Harris R, Nathanson D, Sadeghi S, Ellingson B, Liau L, Prins R. IT-01 * PD1/PDL1 INTERACTIONS MEDIATE SUPPRESSION OF ANTI-TUMOR IMMUNE ACTIVITY IN GLIOMA Neuro-Oncology. 16: v110-v110. DOI: 10.1093/Neuonc/Nou258.1  0.739
2014 Harris R, Cloughesy T, Liau L, Lai A, Nghiemphu P, Li D, Pope W, Ellingson B. BI-10 * pH-WEIGHTED MRI IN HUMAN GLIOMAS Neuro-Oncology. 16: v25-v25. DOI: 10.1093/Neuonc/Nou239.10  0.387
2013 Lasky JL, Panosyan EH, Plant A, Davidson T, Yong WH, Prins RM, Liau LM, Moore TB. Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas. Anticancer Research. 33: 2047-56. PMID 23645755  0.37
2013 Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G, Cloughesy TF, Liau LM. Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 152-7. PMID 23377664 DOI: 10.1097/Cji.0B013E3182811Ae4  0.367
2013 Morris LG, Kaufman AM, Gong Y, Ramaswami D, Walsh LA, Turcan ?, Eng S, Kannan K, Zou Y, Peng L, Banuchi VE, Paty P, Zeng Z, Vakiani E, Solit D, ... ... Liau L, et al. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. Nature Genetics. 45: 253-61. PMID 23354438 DOI: 10.1038/Ng.2538  0.327
2013 Ellingson BM, Lai A, Harris RJ, Selfridge JM, Yong WH, Das K, Pope WB, Nghiemphu PL, Vinters HV, Liau LM, Mischel PS, Cloughesy TF. Probabilistic radiographic atlas of glioblastoma phenotypes. Ajnr. American Journal of Neuroradiology. 34: 533-40. PMID 22997168 DOI: 10.3174/Ajnr.A3253  0.327
2013 Liu Y, Zhang Y, Tso JL, Menjivar JC, Tian JY, Liau L, McBride W, Tso C. Abstract 3765: High-throughput RNAi screening identifies genes controlling glioblastoma stem cell migration and survival. Cancer Research. 73: 3765-3765. DOI: 10.1158/1538-7445.Am2013-3765  0.407
2012 Yang I, Jian Y, Garcia H, Choy W, Nagasawa DT, Spasic M, Trang A, Soto H, Ericcson K, Lisiero D, Hickey M, Kruse C, Prins RM, Rome L, Liau LM. 198 An Antigen Vault Nanoparticle Vaccine Can Effectively Stimulate Dendritic Cells and Activate a Specific T cell Immune Response. Neurosurgery. 71: E576-E577. PMID 28175807 DOI: 10.1227/01.neu.0000417788.76126.66  0.305
2012 Fong B, Jin R, Wang X, Safaee M, Lisiero DN, Yang I, Li G, Liau LM, Prins RM. Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients. Plos One. 7: e32614. PMID 22485134 DOI: 10.1371/Journal.Pone.0032614  0.301
2012 Nagasawa D, Spasic M, Choy W, Garcia H, Trang A, Shafa B, Duong D, Ausman J, Bergsneider M, Liau L, McBride D, Yang I. Analysis of 223 Brain Tumor Patients Treated at a Level 1 Trauma County Medical Center Journal of Neurological Surgery Part B: Skull Base. 73. DOI: 10.1055/S-0032-1312283  0.348
2011 Yamada K, Tso J, Ye F, Choe J, Liu Y, Liau LM, Tso CL. Essential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrence. Cancers. 3: 1975-95. PMID 24212792 DOI: 10.3390/cancers3021975  0.364
2011 Konkankit VV, Kim W, Koya RC, Eskin A, Dam MA, Nelson S, Ribas A, Liau LM, Prins RM. Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway. Journal of Translational Medicine. 9: 192. PMID 22060015 DOI: 10.1186/1479-5876-9-192  0.385
2011 Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1603-15. PMID 21135147 DOI: 10.1158/1078-0432.Ccr-10-2563  0.419
2010 Lee Y, Liu J, Patel S, Cloughesy T, Lai A, Farooqi H, Seligson D, Dong J, Liau L, Becker D, Mischel P, Shams S, Nelson S. Genomic landscape of meningiomas. Brain Pathology (Zurich, Switzerland). 20: 751-62. PMID 20015288 DOI: 10.1111/J.1750-3639.2009.00356.X  0.341
2010 Kim W, Liau LM. Dendritic cell vaccines for brain tumors. Neurosurgery Clinics of North America. 21: 139-57. PMID 19944973 DOI: 10.1016/j.nec.2009.09.005  0.368
2009 Veeriah S, Brennan C, Meng S, Singh B, Fagin JA, Solit DB, Paty PB, Rohle D, Vivanco I, Chmielecki J, Pao W, Ladanyi M, Gerald WL, Liau L, Cloughesy TC, et al. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proceedings of the National Academy of Sciences of the United States of America. 106: 9435-40. PMID 19478061 DOI: 10.1073/Pnas.0900571106  0.396
2008 Prins RM, Odesa S, Soto H, Yong WH, Lai A, Bosch M, Boynton A, Cloughesy TF, Liau LM. Autologous tumor-lysate pulsed dendritic cell vaccination, together with the TLR-7 agonist 5% imiquimod, and serum pro- inflammatory cytokine levels in glioblastoma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 11021. PMID 27947675 DOI: 10.1200/Jco.2008.26.15_Suppl.11021  0.367
2008 Prins RM, Shu CJ, Radu CG, Vo DD, Khan-Farooqi H, Soto H, Yang MY, Lin MS, Shelly S, Witte ON, Ribas A, Liau LM. Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain. Cancer Immunology, Immunotherapy : Cii. 57: 1279-89. PMID 18253732 DOI: 10.1007/S00262-008-0461-1  0.416
2008 Cloughesy TF, Yoshimoto K, Nghiemphu P, Brown K, Dang J, Zhu S, Hsueh T, Chen Y, Wang W, Youngkin D, Liau L, Martin N, Becker D, Bergsneider M, Lai A, et al. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. Plos Medicine. 5: e8. PMID 18215105 DOI: 10.1371/Journal.Pmed.0050008  0.318
2008 Nakano I, Masterman-Smith M, Saigusa K, Paucar AA, Horvath S, Shoemaker L, Watanabe M, Negro A, Bajpai R, Howes A, Lelievre V, Waschek JA, Lazareff JA, Freije WA, Liau LM, et al. Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. Journal of Neuroscience Research. 86: 48-60. PMID 17722061 DOI: 10.1002/Jnr.21471  0.3
2007 Liau LM, Prins RM, Odesa SK, Yang MY, Lin MS, Khan-Farooqi H, Soto H, Lai A, Bosch M, Boynton A, Cloughesy TF. Dendritic cell vaccination in combination with TLR-7 agonist, imiquimod, following radio-chemotherapy for newly diagnosed glioblastoma Journal of Clinical Oncology. 25: 2021-2021. DOI: 10.1200/jco.2007.25.18_suppl.2021  0.445
2006 Prins RM, Vo DD, Khan-Farooqi H, Yang MY, Soto H, Economou JS, Liau LM, Ribas A. NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain. Journal of Immunology (Baltimore, Md. : 1950). 177: 8448-55. PMID 17142742  0.384
2006 Yang MY, Zetler PM, Prins RM, Khan-Farooqi H, Liau LM. Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications. Expert Review of Neurotherapeutics. 6: 1481-94. PMID 17078788 DOI: 10.1586/14737175.6.10.1481  0.391
2006 Tso CL, Shintaku P, Chen J, Liu Q, Liu J, Chen Z, Yoshimoto K, Mischel PS, Cloughesy TF, Liau LM, Nelson SF. Primary glioblastomas express mesenchymal stem-like properties. Molecular Cancer Research : McR. 4: 607-19. PMID 16966431 DOI: 10.1158/1541-7786.MCR-06-0005  0.317
2006 Tso CL, Freije WA, Day A, Chen Z, Merriman B, Perlina A, Lee Y, Dia EQ, Yoshimoto K, Mischel PS, Liau LM, Cloughesy TF, Nelson SF. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Research. 66: 159-67. PMID 16397228 DOI: 10.1158/0008-5472.CAN-05-0077  0.318
2006 Prins RM, Bruhn KW, Craft N, Lin JW, Kim CH, Odesa SK, Miller JF, Liau LM. Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden. Neurosurgery. 58: 169-78; discussion 1. PMID 16385341 DOI: 10.1227/01.Neu.0000192367.29047.64  0.406
2006 Prins RM, Craft N, Bruhn KW, Khan-Farooqi H, Koya RC, Stripecke R, Miller JF, Liau LM. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 176: 157-64. PMID 16365406 DOI: 10.4049/Jimmunol.176.1.157  0.452
2005 Khan-Farooqi HR, Prins RM, Liau LM. Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies. Neurological Research. 27: 692-702. PMID 16197806 DOI: 10.1179/016164105X49490  0.377
2005 Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, Roth MD. Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5515-25. PMID 16061868 DOI: 10.1158/1078-0432.CCR-05-0464  0.431
2005 Craft N, Bruhn KW, Nguyen BD, Prins R, Lin JW, Liau LM, Miller JF. The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine. Journal of Immunology (Baltimore, Md. : 1950). 175: 1983-90. PMID 16034143 DOI: 10.4049/Jimmunol.175.3.1983  0.391
2004 Prins RM, Liau LM. Cellular immunity and immunotherapy of brain tumors. Frontiers in Bioscience : a Journal and Virtual Library. 9: 3124-36. PMID 15353342  0.405
2004 Prins RM, Liau LM. Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done Neuro-Oncology. 6: 265-266. DOI: 10.1215/S1152851703200077  0.333
2004 Chen C, Tao S, Shai R, Mischel P, Liau L, Pinta J, Horvath S, Nelson S, Sawyers C. 315 Molecular signature of the PTEN tumor suppressor-identification of IGFBP2 as a surrogate marker for PTEN/Akt signaling European Journal of Cancer Supplements. 2: 96. DOI: 10.1016/S1359-6349(04)80323-9  0.359
2003 Prins RM, Odesa SK, Liau LM. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model. Cancer Research. 63: 8487-91. PMID 14679014  0.351
2003 Broder H, Anderson A, Kremen TJ, Odesa SK, Liau LM. MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor. Journal of Neuro-Oncology. 64: 21-30. PMID 12952283 DOI: 10.1007/BF02700017  0.381
2002 Liau LM, Jensen ER, Kremen TJ, Odesa SK, Sykes SN, Soung MC, Miller JF, Bronstein JM. Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination. Cancer Research. 62: 2287-93. PMID 11956085  0.596
2000 Liau LM, Black KL, Martin NA, Sykes SN, Bronstein JM, Jouben-Steele L, Mischel PS, Belldegrun A, Cloughesy TF. Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report. Neurosurgical Focus. 9: e8. PMID 16817691 DOI: 10.3171/foc.2000.9.6.9  0.618
2000 Broder H, Anderson A, Odesa SK, Kremen TJ, Liau LM. Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor. Neurosurgical Focus. 9: e6. PMID 16817689  0.394
2000 Liau LM, Lallone RL, Seitz RS, Buznikov A, Gregg JP, Kornblum HI, Nelson SF, Bronstein JM. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Cancer Research. 60: 1353-60. PMID 10728698  0.521
1999 Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. Journal of Neurosurgery. 90: 1115-24. PMID 10350260 DOI: 10.3171/jns.1999.90.6.1115  0.606
1999 Liau LM, Fakhrai H, Black KL. Prolonged survival of rats with intracranial C6 gliomas by treatment with TGF-beta antisense gene. Neurological Research. 20: 742-7. PMID 9864741 DOI: 10.1080/01616412.1998.11740594  0.331
Low-probability matches (unlikely to be authored by this person)
2005 Mehrian Shai R, Reichardt JK, Ya-Hsuan H, Kremen TJ, Liau LM, Cloughesy TF, Mischel PS, Nelson SF. Robustness of gene expression profiling in glioma specimen samplings and derived cell lines. Brain Research. Molecular Brain Research. 136: 99-103. PMID 15893592 DOI: 10.1016/j.molbrainres.2005.01.017  0.294
2023 Patel KS, Yao J, Cho NS, Sanvito F, Tessema K, Alvarado A, Dudley L, Rodriguez F, Everson R, Cloughesy TF, Salamon N, Liau L, Kornblum H, Ellingson BM. pH-Weighted Amine Chemical Exchange Saturation Transfer Echo Planar Imaging (CEST-EPI) Visualizes Infiltrating Glioblastoma Cells. Neuro-Oncology. PMID 37591790 DOI: 10.1093/neuonc/noad150  0.292
2014 Classen CF, William D, Linnebacher M, Farhod A, Kedr W, Elsabe B, Fadel S, Van Gool S, De Vleeschouwer S, Koks C, Garg A, Ehrhardt M, Riva M, De Vleeschouwer S, Agostinis P, ... ... Liau L, et al. HIGH GRADE GLIOMAS AND DIPG Neuro-Oncology. 16: i40-i59. DOI: 10.1093/Neuonc/Nou071  0.29
2018 Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, et al. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. Journal of Translational Medicine. 16: 142. PMID 29843811 DOI: 10.1186/S12967-018-1507-6  0.29
2019 Wang YL, Yao J, Chakhoyan A, Raymond C, Salamon N, Liau LM, Nghiemphu PL, Lai A, Pope WB, Nguyen N, Ji M, Cloughesy TF, Ellingson BM. Association between Tumor Acidity and Hypervascularity in Human Gliomas Using pH-Weighted Amine Chemical Exchange Saturation Transfer Echo-Planar Imaging and Dynamic Susceptibility Contrast Perfusion MRI at 3T. Ajnr. American Journal of Neuroradiology. PMID 31097430 DOI: 10.3174/ajnr.A6063  0.289
2015 Lim M, Liau LM. Introduction: brain tumor immunotherapy. Journal of Neuro-Oncology. 123: 321-2. PMID 26113108 DOI: 10.1007/s11060-015-1848-4  0.288
2015 Lim M, Liau LM. Introduction: brain tumor immunotherapy Journal of Neuro-Oncology. DOI: 10.1007/s11060-015-1848-4  0.288
2022 Cho NS, Hagiwara A, Yao J, Nathanson DA, Prins RM, Wang C, Raymond C, Desousa BR, Divakaruni A, Morrow DH, Nghiemphu PL, Lai A, Liau LM, Everson RG, Salamon N, et al. Amine-weighted chemical exchange saturation transfer (CEST) MRI in brain tumors. Nmr in Biomedicine. e4785. PMID 35704275 DOI: 10.1002/nbm.4785  0.287
2014 Harris RJ, Bookheimer SY, Cloughesy TF, Kim HJ, Pope WB, Lai A, Nghiemphu PL, Liau LM, Ellingson BM. Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI. Journal of Neuro-Oncology. 116: 373-9. PMID 24234804 DOI: 10.1007/s11060-013-1304-2  0.287
2016 Cloughesy T, Walbert T, Bota D, Vogelbaum M, Liau L, Ostertag D, Jolly D, Gruber H, Yang L, Shorr J, Kalkanis S. ATIM-02. SUCCESSFUL CANCER-SELECTIVE GENE DELIVERY FOLLOWING INTRAVENOUS TOCA 511 DELIVERY IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (HGG) Neuro-Oncology. 18: vi17-vi17. DOI: 10.1093/Neuonc/Now212.067  0.287
2006 Liau LM. Dendritic cell vaccination in patients with malignant gliomas: Current status and future directions - Commentary Neurosurgery. 59: 999. DOI: 10.1227/01.NEU.0000245595.38957.3E  0.286
2014 Cloughesy TF, Kesari S, Kalkanis S, Mikkelsen T, Landolfi J, Elder JB, Liau LM, Chen CC, Bloomfield S, Piccioni D, Chiocca EA, Foltz G, Robbins JM, Ostertag D, Jolly DJ, et al. IT-05 * ADMINISTRATION OF TOCA 511 TO SUBJECTS WITH RECURRENT HGG UNDERGOING REPEAT RESECTION Neuro-Oncology. 16: v110-v111. DOI: 10.1093/Neuonc/Nou258.4  0.285
2021 Tatekawa H, Uetani H, Hagiwara A, Bahri S, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden. Annals of Nuclear Medicine. PMID 34121166 DOI: 10.1007/s12149-021-01637-0  0.282
2010 Hickey MJ, Malone CC, Erickson KL, Jadus MR, Prins RM, Liau LM, Kruse CA. Cellular and vaccine therapeutic approaches for gliomas. Journal of Translational Medicine. 8: 100. PMID 20946667 DOI: 10.1186/1479-5876-8-100  0.281
2015 Ellingson B, Leu K, Pope W, Lai A, Nghiemphu P, Liau L, Cloughesy T. NIMG-24HIGH SPATIOTEMPORAL DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) PERFUSION MRI USING MULTIBAND ECHOPLANAR IMAGING (MB-EPI) Neuro-Oncology. 17: v158.4-v159. DOI: 10.1093/Neuonc/Nov225.24  0.28
2009 Laks DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I, Yong WH, Vinters HV, Liau LM, Lazareff JA, Mischel PS, Cloughesy TF, Horvath S, Kornblum HI. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells (Dayton, Ohio). 27: 980-7. PMID 19353526 DOI: 10.1002/Stem.15  0.279
2013 Leu K, Pope WB, Cloughesy TF, Lai A, Nghiemphu PL, Chen W, Liau LM, Ellingson BM. Imaging biomarkers for antiangiogenic therapy in malignant gliomas. Cns Oncology. 2: 33-47. PMID 24570837 DOI: 10.2217/cns.12.29  0.279
2005 Boudreau CR, Yang I, Liau LM. Gliomas: advances in molecular analysis and characterization. Surgical Neurology. 64: 286-94; discussion 2. PMID 16229087  0.277
2015 Leu K, Boxerman J, Cloughesy T, Lai A, Nghiemphu P, Liau L, Pope W, Ellingson B. NIMG-25IMPROVED LEAKAGE CORRECTION FOR DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) PERFUSION MRI ESTIMATES OF RELATIVE CEREBRAL BLOOD VOLUME (rCBV) IN HIGH-GRADE GLIOMAS BY ACCOUNTING FOR BIDIRECTIONAL CONTRAST AGENT EXCHANGE Neuro-Oncology. 17: v159.1-v159. DOI: 10.1093/Neuonc/Nov225.25  0.277
2010 Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, Ladanyi M, Sander C, Heguy A, Holland EC, Paty PB, ... ... Liau L, et al. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nature Genetics. 42: 77-82. PMID 19946270 DOI: 10.1038/Ng.491  0.276
2015 Yong WH, Shabihkhani M, Telesca D, Yang S, Tso JL, Menjivar JC, Wei B, Lucey GM, Mareninov S, Chen Z, Liau LM, Lai A, Nelson SF, Cloughesy TF, Tso CL. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients. Plos One. 10: e0141334. PMID 26506620 DOI: 10.1371/Journal.Pone.0141334  0.273
2012 Chou AP, Chowdhury R, Li S, Chen W, Kim AJ, Piccioni DE, Selfridge JM, Mody RR, Chang S, Lalezari S, Lin J, Sanchez DE, Wilson RW, Garrett MC, Harry B, ... ... Liau LM, et al. Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas. Journal of the National Cancer Institute. 104: 1458-69. PMID 22945948 DOI: 10.1093/Jnci/Djs357  0.273
2017 Figueroa JM, Skog J, Akers J, Li H, Komotar R, Jensen R, Ringel F, Yang I, Kalkanis S, Thompson R, LoGuidice L, Berghoff E, Parsa A, Liau L, Curry W, et al. Detection of wtEGFR Amplification and EGFRvIII Mutation in CSF-Derived Extracellular Vesicles of Glioblastoma Patients. Neuro-Oncology. PMID 28453784 DOI: 10.1093/Neuonc/Nox085  0.272
2008 Prins RM, Cloughesy TF, Liau LM. Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. The New England Journal of Medicine. 359: 539-41. PMID 18669440 DOI: 10.1056/NEJMc0804818  0.268
2012 Yang J, Nagasawa DT, Spasic M, Amolis M, Choy W, Garcia HM, Prins RM, Liau LM, Yang I. Endogenous vaults and bioengineered vault nanoparticles for treatment of glioblastomas: implications for future targeted therapies. Neurosurgery Clinics of North America. 23: 451-8. PMID 22748657 DOI: 10.1016/j.nec.2012.04.012  0.267
2023 Wetzel EA, Farrell MJ, Eldred BSC, Liu V, Saha I, Zapanta Rinonos S, Prins T, Li T, Cao M, Hegde J, Kaprealian T, Khanlou N, Liau LM, Nghiemphu PL, Cloughesy TF, et al. Retrospective examination of pseudoprogression in mutant gliomas. Neuro-Oncology Advances. 5: vdad028. PMID 37128507 DOI: 10.1093/noajnl/vdad028  0.266
2019 McKinney A, Lindberg OR, Engler JR, Chen KY, Kumar A, Gong H, Lu KV, Simonds EF, Cloughesy TF, Liau LM, Prados M, Bollen AW, Berger MS, Shieh JTC, James CD, et al. Mechanisms of resistance to EGFR inhibition reveal metabolic vulnerabilities in human GBM. Molecular Cancer Therapeutics. PMID 31270152 DOI: 10.1158/1535-7163.Mct-18-1330  0.265
2021 Tatekawa H, Uetani H, Hagiwara A, Yao J, Oughourlian TC, Ueda I, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Bahri S, Pope WB, Salamon N, Ellingson BM. Preferential tumor localization in relation to F-FDOPA uptake for lower-grade gliomas. Journal of Neuro-Oncology. PMID 33704629 DOI: 10.1007/s11060-021-03730-w  0.265
2006 Lasky JL, Liau LM. Targeting stem cells in brain tumors. Technology in Cancer Research & Treatment. 5: 251-60. PMID 16700621  0.264
2014 Banerjee P, Leu K, Harris R, Cloughesy T, Bookheimer S, Liau L, Nghiemphu P, Lai A, Ellingson B. NC-01 * ATTENTIONAL AND LANGUAGE FUNCTIONING IN ADULT PATIENTS WITH GLIOMA: A VOXEL-BASED LESION-SYMPTOM MAPPING STUDY Neuro-Oncology. 16: v134-v134. DOI: 10.1093/Neuonc/Nou263.1  0.263
2004 Boudreau CR, Liau LM. Molecular characterization of brain tumors. Clinical Neurosurgery. 51: 81-90. PMID 15571131  0.263
2012 Hickey MJ, Malone CC, Erickson KE, Gomez GG, Young EL, Liau LM, Prins RM, Kruse CA. Implementing preclinical study findings to protocol design: translational studies with alloreactive CTL for gliomas. American Journal of Translational Research. 4: 114-26. PMID 22347526  0.263
2008 Liau LM. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas: Commentary Neurosurgery. 62: 515. DOI: 10.1227/01.Neu.0000316019.28421.95  0.261
2010 Sun J, Masterman-Smith MD, Graham NA, Jiao J, Mottahedeh J, Laks DR, Ohashi M, DeJesus J, Kamei K, Lee KB, Wang H, Yu ZT, Lu YT, Hou S, Li K, ... ... Liau LM, et al. A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens. Cancer Research. 70: 6128-38. PMID 20631065 DOI: 10.1158/0008-5472.Can-10-0076  0.261
2014 Li S, Chowdhury R, Liu F, Chou AP, Li T, Mody RR, Lou JJ, Chen W, Reiss J, Soto H, Prins R, Liau LM, Mischel PS, Nghiemphu PL, Yong WH, et al. Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5808-22. PMID 25224277 DOI: 10.1158/1078-0432.Ccr-14-0234  0.26
2008 Lelievre V, Seksenyan A, Nobuta H, Yong WH, Chhith S, Niewiadomski P, Cohen JR, Dong H, Flores A, Liau LM, Kornblum HI, Scott MP, Waschek JA. Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice. Developmental Biology. 313: 359-70. PMID 18036580 DOI: 10.1016/J.Ydbio.2007.10.031  0.257
2017 Kong X, Nguyen N, Choi Y, Zhang G, Nguyen H, Filka E, Green S, Yong W, Liau L, Kaprealian T, Pope W, Nghiemphu P, Cloughesy T, Lassman A, Lai A. ACTR-53. SAFETY AND EFFICACY EVALUATION OF A PHASE II STUDY OF BORTEZOMIB IN COMBINATION WITH TEMOZOLOMIDE AND REGIONAL RADIATION THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) Neuro-Oncology. 19: vi12-vi12. DOI: 10.1093/Neuonc/Nox168.044  0.256
2016 Harris R, Liau L, Leu K, Nghiemphu P, Pope W, Lai A, Cloughesy T, Ellingson B. NIMG-54. AMINE CEST MRI, A FAST AMINO ACID AND PH-WEIGHTED MOLECULAR IMAGING TECHNIQUE, CORRELATES WITH 18F-FDOPA PET AND IMAGE-GUIDED BIOPSY IN HUMAN GLIOMA Neuro-Oncology. 18: vi136-vi136. DOI: 10.1093/Neuonc/Now212.565  0.255
2014 Aghi M, Vogelbaum MA, Kesari S, Chen CC, Liau LM, Piccioni D, Portnow J, Chang S, Robbins JM, Boyce T, Huang TT, Pertschuk D, Ostertag D, Cloughesy TF. AT-02 * INTRATUMORAL DELIVERY OF THE RETROVIRAL REPLICATING VECTOR (RRV) TOCA 511 IN SUBJECTS WITH RECURRENT HIGH GRADE GLIOMA: INTERIM REPORT OF PHASE 1 STUDY (NCT 01156584) Neuro-Oncology. 16: v8-v8. DOI: 10.1093/Neuonc/Nou237.2  0.254
2006 Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, Lee Y, Scheck AC, Liau LM, Wu H, Geschwind DH, et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proceedings of the National Academy of Sciences of the United States of America. 103: 17402-7. PMID 17090670 DOI: 10.1073/pnas.0608396103  0.253
2021 Hagiwara A, Oughourlian TC, Cho NS, Schlossman J, Wang C, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Rodriguez FJ, Salamon N, Pope WB, Nghiemphu PL, Liau LM, et al. Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors. Neuro-Oncology. PMID 34865129 DOI: 10.1093/neuonc/noab276  0.252
2010 Kappadakunnel M, Eskin A, Dong J, Nelson SF, Mischel PS, Liau LM, Ngheimphu P, Lai A, Cloughesy TF, Goldin J, Pope WB. Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone. Journal of Neuro-Oncology. 96: 359-67. PMID 19655089 DOI: 10.1007/s11060-009-9983-4  0.252
2016 Aghi M, Vogelbaum M, Kalkanis S, Bota D, Carter B, Chen C, Elder B, Engh J, Goldlust S, Kaptain G, Kesari S, Landolfi J, Liau L, Mikkelsen T, Piccioni D, et al. ATIM-05. COMPLEMENTARY CLINICAL AND ANCILLARY DATA FROM 123 PATIENTS WITH RECURRENT HIGH GRADE GLIOMA FROM THREE PHASE 1 TRIALS OF TOCA 511 AND TOCA FC: UPDATE AND JUSTIFICATION FOR A PHASE 2/3 TRIAL Neuro-Oncology. 18: vi18-vi18. DOI: 10.1093/Neuonc/Now212.070  0.252
2020 Ji MS, Eldred BSC, Liu R, Pianka ST, Molaie D, Kevan B, Pan S, Lai TJ, Nguyen NT, Chow FE, Yong WH, Cox CD, Reeh DN, Li T, Liau LM, et al. Targeted next-generation sequencing of 565 neuro-oncology patients at UCLA: A single-institution experience. Neuro-Oncology Advances. 2: vdaa009. PMID 32118206 DOI: 10.1093/noajnl/vdaa009  0.251
2019 Dovek L, Nguyen NT, Ozer BH, Li N, Elashoff RM, Green RM, Liau L, Nghiemphu PL, Cloughesy TF, Lai A. Correlation of commercially available quantitative (O-6-methylguanine-DNA methyltransferase) promoter methylation scores and GBM patient survival. Neuro-Oncology Practice. 6: 194-202. PMID 31386024 DOI: 10.1093/Nop/Npy028  0.251
2015 Erickson KL, Hickey MJ, Kato Y, Malone CC, Owens GC, Prins RM, Liau LM, Kasahara N, Kruse CA. Radial mobility and cytotoxic function of retroviral replicating vector transduced, non-adherent alloresponsive T lymphocytes. Journal of Visualized Experiments : Jove. PMID 25741775 DOI: 10.3791/52416  0.251
2012 Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, Salamon N, Chou AP, Yong WH, Soto H, Wilson N, Driggers E, Jang HG, Su SM, Schenkein DP, ... ... Liau LM, et al. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. Journal of Neuro-Oncology. 107: 197-205. PMID 22015945 DOI: 10.1007/S11060-011-0737-8  0.249
2010 Yang I, Liau LM. American Association for Cancer Research Genetics and Biology of Brain Cancers 2009, December 13-15, 2009, San Diego, CA. Journal of Neuro-Oncology. 99: 297-306. PMID 20714783 DOI: 10.1007/s11060-010-0332-4  0.249
2016 Leu K, Cloughesy T, Liau L, Nghiemphu P, Lai A, Pope W, Ellingson B. NIMG-56. PATTERNS FROM DYNAMIC VESSEL SIZE IMAGING OF ARTERIAL AND VENOUS PERFUSION CORRELATES WITH AGGRESSIVENESS AND STRATIFIES 1p19q CO-DELETED FROM NON-CODELETED LOW-GRADE GLIOMAS Neuro-Oncology. 18: vi136-vi137. DOI: 10.1093/Neuonc/Now212.567  0.248
2016 Everson R, Tucker A, Garrett M, Marcus L, Harris R, Prins R, Ellingson B, Liau L. SURG-21. CASE-MATCHED STUDY OF EFFECT OF INTRA-OPERATIVE MRI ON EXTENT OF RESECTION AND CLINICAL OUTCOME IN GLIOMA PATIENTS UNDERGOING SURGICAL RESECTION Neuro-Oncology. 18: vi195-vi195. DOI: 10.1093/Neuonc/Now212.822  0.247
2005 Craft N, Bruhn KW, Nguyen BD, Prins R, Liau LM, Collisson EA, De A, Kolodney MS, Gambhir SS, Miller JF. Bioluminescent imaging of melanoma in live mice. The Journal of Investigative Dermatology. 125: 159-65. PMID 15982316 DOI: 10.1111/J.0022-202X.2005.23759.X  0.245
2023 Baisiwala S, Ko M, Zubair H, Li K, Vivas AC, Everson R, Liau L, Bari A, Patel KS. Metastatic secondary gliosarcoma: patient series. Journal of Neurosurgery. Case Lessons. 5. PMID 37218733 DOI: 10.3171/CASE232  0.244
2013 Campian J, Gladstone D, Ambady P, Ye X, King K, Borrello I, Petrik S, Golightly M, Holdhoff M, Grossman S, Bhardwaj R, Chakravadhanula M, Ozols V, Georges J, Carlson E, ... ... Liau LM, ... ... Liau L, ... ... Liau L, et al. IMMUNOTHERAPY/BIOLOGICAL THERAPIES Neuro-Oncology. 15: iii68-iii74. DOI: 10.1093/Neuonc/Not178  0.244
2011 Lisiero DN, Soto H, Liau LM, Prins RM. Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12-primed CD8(+) T cells in a melanoma model. Journal of Immunology (Baltimore, Md. : 1950). 186: 5068-77. PMID 21430221 DOI: 10.4049/Jimmunol.1003317  0.244
2013 Papour A, Taylor Z, Sherman A, Sanchez D, Lucey G, Liau L, Stafsudd O, Yong W, Grundfest W. Optical imaging for brain tissue characterization using relative fluorescence lifetime imaging. Journal of Biomedical Optics. 18: 60504. PMID 23760460 DOI: 10.1117/1.Jbo.18.6.060504  0.243
2017 Ozer B, Bui Y, Markovic D, Nguyen H, Liau L, Nghiemphu P, Cloughesy T, Lai A. NCMP-01. SEIZURE CONTROL AFTER INITIAL PRESENTATION IN IDH MUTATED GLIOMA PATIENTS Neuro-Oncology. 19: vi135-vi136. DOI: 10.1093/Neuonc/Nox168.555  0.242
2012 Kim W, Liau LM. IDH mutations in human glioma. Neurosurgery Clinics of North America. 23: 471-80. PMID 22748659 DOI: 10.1016/j.nec.2012.04.009  0.242
2007 Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, ... ... Liau L, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proceedings of the National Academy of Sciences of the United States of America. 104: 20007-12. PMID 18077431 DOI: 10.1073/Pnas.0710052104  0.241
2018 Chakhoyan A, Leu K, Harris R, Pope W, Salamon N, Yong W, Lai A, Liau L, Nghiemphu P, Cloughesy T, Ellingson B. NIMG-59. VALIDATION OF QUANTITATIVE VESSEL SIZE IMAGING (VSI) IN HUMAN GLIOMAS USING IMAGE-GUIDED STEREOTACTIC BIOPSIES Neuro-Oncology. 20: vi189-vi189. DOI: 10.1093/Neuonc/Noy148.784  0.241
2016 Harris R, Liau L, Leu K, Nghiemphu P, Pope W, Lai A, Cloughesy T, Ellingson B. NIMG-55. SIMULTANEOUS QUANTITATIVE PH MAPPING AND HYPOXIA IMAGING USING FAST MULTI-ECHO AMINE CEST-EPI IN HUMAN GLIOMAS Neuro-Oncology. 18: vi136-vi136. DOI: 10.1093/Neuonc/Now212.566  0.238
2011 Liu Y, Ye F, Yamada K, Tso JL, Zhang Y, Nguyen DH, Dong Q, Soto H, Choe J, Dembo A, Wheeler H, Eskin A, Schmid I, Yong WH, Mischel PS, ... ... Liau LM, et al. Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells. Molecular Cancer Research : McR. 9: 1668-85. PMID 22013079 DOI: 10.1158/1541-7786.Mcr-10-0563  0.237
2012 Pertschuk D, Cloughesy TF, Chang SM, Aghi MK, Vogelbaum MA, Liau LM, Shafa BB, Yong WH, Chen C, Kesari S, Ibanez CE, Perez OD, Robbins JM, Jolly DJ, Gruber HE. Ascending dose trials of the safety and tolerability of Toca 511, a retroviral replicating vector encoding cytosine deaminase, in patients with recurrent high-grade glioma. Journal of Clinical Oncology. 30: 2101-2101. DOI: 10.1200/Jco.2012.30.15_Suppl.2101  0.237
2018 Yao J, Chakhoyan A, Ellingson B, Pope W, Salamon N, Yong W, Lai A, Liau L, Nghiemphu P, Cloughesy T. NIMG-15. DIFFERENTIATION OF IDH1 MUTANT AND WILD TYPE GLIOMAS USING pH- AND OXYGEN-SENSITIVE MOLECULAR MRI Neuro-Oncology. 20: vi178-vi179. DOI: 10.1093/Neuonc/Noy148.742  0.237
2021 Skowron P, Farooq H, Cavalli FMG, Morrissy AS, Ly M, Hendrikse LD, Wang EY, Djambazian H, Zhu H, Mungall KL, Trinh QM, Zheng T, Dai S, Stucklin ASG, Vladoiu MC, ... ... Liau LM, et al. The transcriptional landscape of Shh medulloblastoma. Nature Communications. 12: 1749. PMID 33741928 DOI: 10.1038/s41467-021-21883-0  0.235
2020 Patel KS, Yao J, Raymond C, Yong W, Everson R, Liau LM, Nathanson D, Kornblum H, Wang C, Oughourlian T, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma. Scientific Reports. 10: 14819. PMID 32908231 DOI: 10.1038/S41598-020-71799-W  0.234
2015 Liu F, Chowdhury R, Li T, Li S, Nguyen H, Wei B, Chou AP, Reiss JK, Mody RR, Liau LM, Nghiemphu PL, Yong WH, Cloughesy T, Lai A. EPIG-11THE IMPLICATION OF CpG island AND SPINT2 HYPERMETHYLATION IN BOTH IDH1 WILD-TYPE AND MUTANT ADULT DIFFUSE GLIOMAS Neuro-Oncology. 17: v88.3-v88. DOI: 10.1093/Neuonc/Nov214.11  0.234
2007 Liau LM. Intraventricular dysembryoplastic neuroepithelial tumor: Case report - Commentary Neurosurgery. 61: E1333. DOI: 10.1227/01.neu.0000306114.08540.aa  0.232
2023 Minami JK, Morrow D, Bayley NA, Fernandez EG, Salinas JJ, Tse C, Zhu H, Su B, Plawat R, Jones A, Sammarco A, Liau LM, Graeber TG, Williams KJ, Cloughesy TF, et al. CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. Cancer Cell. PMID 37236196 DOI: 10.1016/j.ccell.2023.05.001  0.231
2017 Ozer B, Chowdhury R, Li T, Bui Y, Nguyen N, Yong W, Liau L, Nghiemphu P, Cloughesy T, Lai A. GENE-41. EPIGENETIC DOWN-REGULATION OF THE METALLOTHIONEIN FAMILY IN ISOCITRATE DEHYDROGENASE (IDH) MUTANT GLIOMAS Neuro-Oncology. 19: vi101-vi101. DOI: 10.1093/Neuonc/Nox168.414  0.23
2016 Vogelbaum M, Lassman A, Lee I, Liau L, Sonabend A, Walbert T, Yang L, Das A, Cloughesy T. ACTR-06. THE TOCA 7 STUDY: PHASE 1B STUDY OF TOCA 511, A LIVE GAMMA RETROVIRUS, AND TOCA FC, AN EXTENDED-RELEASE FORMULATION OF 5-FLUOROCYTOSINE COMBINED WITH STANDARD OF CARE IN NEWLY DIAGNOSED HIGH GRADE GLIOMA (NCT02598011) Neuro-Oncology. 18: vi2-vi2. DOI: 10.1093/Neuonc/Now212.005  0.229
2013 Choy W, Nagasawa D, Trang A, Spasic M, Ooi Y, Terterov S, Yong W, Liau L, Martin N, DeSalles A, Kaprealian T, Selch M, Berg M. Prognostic Factors for Tumor Control Following Surgical Resection and Adjuvant Radiotherapy for Intracranial Chordomas Journal of Neurological Surgery Part B: Skull Base. 74. DOI: 10.1055/S-0033-1336176  0.229
2017 Lillehei KO, Kalkanis SN, Liau LM, Mydland DE, Olson J, Paleologos NA, Ryken T, Johnson T, Scullin E. Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry. Cns Oncology. PMID 29206049 DOI: 10.2217/cns-2017-0036  0.228
2017 Dovek L, Nguyen N, Ozer B, Liau L, Nghiemphu P, Cloughesy T, Lai A. PATH-17. CORRELATION OF COMMERCIALLY-AVAILABLE QUANTITATIVE MGMT (O-6-METHYLGUANINE-DNA METHYLTRANSFERASE) METHYLATION SCORES AND OVERALL GBM PATIENT SURVIVAL Neuro-Oncology. 19: vi174-vi174. DOI: 10.1093/Neuonc/Nox168.708  0.226
2009 Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, Liu OY, Tso JL, Liu JY, Konkankit V, Cloughesy TF, Mischel PS, Lane TF, Liau LM, Nelson SF, Tso CL. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. Journal of Neuro-Oncology. 94: 1-19. PMID 19468690 DOI: 10.1007/s11060-009-9919-z  0.225
2019 Lim-Fat MJ, Bi WL, Lo J, Lee EQ, Ahluwalia MS, Batchelor TT, Chang SM, Chiocca EA, Chukwueke U, Cloughesy TF, Colman H, Deangelis LM, Galanis E, Gilbert MR, De Groot JF, ... ... Liau LM, et al. Letter: When Less is More: Dexamethasone Dosing for Brain Tumors. Neurosurgery. PMID 31215634 DOI: 10.1093/Neuros/Nyz186  0.224
2021 Sharaf R, Pavlick DC, Frampton GM, Cooper M, Jenkins J, Danziger N, Haberberger J, Alexander BM, Cloughesy T, Yong WH, Liau LM, Nghiemphu PL, Ji M, Lai A, Ramkissoon SH, et al. FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas. Neuro-Oncology Advances. 3: vdab017. PMID 33778493 DOI: 10.1093/noajnl/vdab017  0.223
2011 Lee Y, Liu J, Patel S, Cloughesy T, Lai A, Farooqi H, Seligson D, Dong J, Liau L, Becker D, Mischel P, Shams S, Nelson S. Erratum: Genomic Landscape of Meningiomas (Brain Pathology (2010) 20 (751-762)) Brain Pathology. 21. DOI: 10.1111/J.1750-3639.2011.00503.X  0.222
2009 Liau LM. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells: Commentary Neurosurgery. 65: 624. DOI: 10.1227/01.NEU.0000350227.61132.A7  0.221
2003 Prins RM, Liau LM. Immunology and immunotherapy in neurosurgical disease. Neurosurgery. 53: 144-52; discussion 1. PMID 12823883 DOI: 10.1227/01.neu.0000068865.34216.3a  0.22
2013 Chen WW, Balaj L, Liau LM, Samuels ML, Kotsopoulos SK, Maguire CA, Loguidice L, Soto H, Garrett M, Zhu LD, Sivaraman S, Chen C, Wong ET, Carter BS, Hochberg FH, et al. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Molecular Therapy. Nucleic Acids. 2: e109. PMID 23881452 DOI: 10.1038/Mtna.2013.28  0.22
2013 Li S, Chou AP, Chen W, Chen R, Deng Y, Phillips HS, Selfridge J, Zurayk M, Lou JJ, Everson RG, Wu KC, Faull KF, Cloughesy T, Liau LM, Lai A. Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation. Neuro-Oncology. 15: 57-68. PMID 23115158 DOI: 10.1093/Neuonc/Nos261  0.219
2016 Ellingson BM, Nguyen HN, Lai A, Nechifor RE, Zaw O, Pope WB, Yong WH, Nghiemphu PL, Liau LM, Cloughesy TF. Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma. Cancer. PMID 26998740 DOI: 10.1002/Cncr.29957  0.217
2012 Lazovic J, Soto H, Piccioni D, Lou JR, Li S, Mirsadraei L, Yong W, Prins R, Liau LM, Ellingson BM, Cloughesy TF, Lai A, Pope WB. Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. Neuro-Oncology. 14: 1465-72. PMID 23090985 DOI: 10.1093/Neuonc/Nos258  0.217
2020 Tatekawa H, Hagiwara A, Uetani H, Yao J, Oughourlian TC, Bahri S, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas. Journal of Neuro-Oncology. PMID 32929644 DOI: 10.1007/s11060-020-03613-6  0.215
2023 He L, Ioannidis A, Arambula E, Hoffman CJ, Joshi P, Kathiravan A, Whitelegge J, Liau LM, Kornblum HI, Pajonk F. Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1. Biorxiv : the Preprint Server For Biology. PMID 37546917 DOI: 10.1101/2023.07.23.550205  0.215
2004 Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF. Gene expression profiling of gliomas strongly predicts survival. Cancer Research. 64: 6503-10. PMID 15374961 DOI: 10.1158/0008-5472.CAN-04-0452  0.214
2018 Cavalli FMG, Hübner JM, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, ... ... Liau LM, et al. Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathologica. PMID 30019219 DOI: 10.1007/S00401-018-1888-X  0.213
2016 Cloughesy TF, Landolfi J, Hogan DJ, Bloomfield S, Carter B, Chen CC, Elder JB, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu PL, Piccioni D, et al. Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma. Science Translational Medicine. 8: 341ra75. PMID 27252174 DOI: 10.1126/Scitranslmed.Aad9784  0.21
2022 Hagiwara A, Tatekawa H, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Yong WH, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI. Scientific Reports. 12: 1078. PMID 35058510 DOI: 10.1038/s41598-022-05077-2  0.208
2013 Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB. Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy. Neuro-Oncology. 15: 382-90. PMID 23275575 DOI: 10.1093/neuonc/nos314  0.208
2007 Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, Macconnaill LE, Lee JC, Nicoletti R, Hatton C, Goyette M, ... ... Liau LM, et al. High-throughput oncogene mutation profiling in human cancer. Nature Genetics. 39: 347-51. PMID 17293865 DOI: 10.1038/Ng1975  0.204
2015 Tso JL, Yang S, Menjivar JC, Yamada K, Zhang Y, Hong I, Bui Y, Stream A, McBride WH, Liau LM, Nelson SF, Cloughesy TF, Yong WH, Lai A, Tso CL. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide. Molecular Cancer. 14: 189. PMID 26546412 DOI: 10.1186/S12943-015-0459-1  0.203
2011 Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, ... ... Liau LM, et al. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4482-90. PMID 22025148 DOI: 10.1200/Jco.2010.33.8715  0.203
2013 Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC, Castelo-Branco P, Baskin B, Ray PN, Bouffet E, von Bueren AO, Jones DT, Northcott PA, Kool M, Sturm D, ... ... Liau LM, et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2927-35. PMID 23835706 DOI: 10.1200/Jco.2012.48.5052  0.202
2012 Yang I, Choy W, Kim W, Alakandy L, Voth B, Prins RM, Liau LM. Active immunotherapy in glioma: Focus on cell-based approaches Drugs of the Future. 37: 19-31. DOI: 10.1358/dof.2012.37.1.1703571  0.199
2016 Ahn C, White P, Liau LM, Cloughesy TF, Nghiemphu PL. Development of an integrated practice unit: Utilizing a lean approach to impact value of care for brain tumor patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 99. PMID 28152815 DOI: 10.1200/jco.2016.34.7_suppl.99  0.196
2009 Liau LM. Antitumor treatment using interleukin-12-secreting marrow stromal cells in an invasive glioma model: Commentary Neurosurgery. 64: 1146-1147. DOI: 10.1227/01.NEU.0000345646.85472.EA  0.194
2002 Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 2894-901. PMID 12231534  0.194
2005 Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, Riggs BL, Horvath S, Liau LM, Cavenee WK, Rao PN, et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. The New England Journal of Medicine. 353: 2012-24. PMID 16282176 DOI: 10.1056/Nejmoa051918  0.193
2013 Ye F, Zhang Y, Liu Y, Yamada K, Tso JL, Menjivar JC, Tian JY, Yong WH, Schaue D, Mischel PS, Cloughesy TF, Nelson SF, Liau LM, McBride W, Tso CL. Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence. Plos One. 8: e80397. PMID 24260384 DOI: 10.1371/Journal.Pone.0080397  0.193
2009 McGillicuddy LT, Fromm JA, Hollstein PE, Kubek S, Beroukhim R, De Raedt T, Johnson BW, Williams SM, Nghiemphu P, Liau LM, Cloughesy TF, Mischel PS, Parret A, Seiler J, Moldenhauer G, et al. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. Cancer Cell. 16: 44-54. PMID 19573811 DOI: 10.1016/J.Ccr.2009.05.009  0.189
2005 Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, Mischel P, Czernin J, Phelps ME, Silverman DH. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 945-52. PMID 15937304  0.189
2007 Carlson MR, Pope WB, Horvath S, Braunstein JG, Nghiemphu P, Tso CL, Mellinghoff I, Lai A, Liau LM, Mischel PS, Dong J, Nelson SF, Cloughesy TF. Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2592-8. PMID 17473188 DOI: 10.1158/1078-0432.CCR-06-2772  0.189
2015 Karavaeva E, Harris RJ, Leu K, Shabihkhani M, Yong WH, Pope WB, Lai A, Nghiemphu PL, Liau LM, Chen W, Czernin J, Cloughesy TF, Ellingson BM. Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 434-42. PMID 25465392 DOI: 10.1007/S11307-014-0807-3  0.188
2019 Lillehei K, Kalkanis S, Liau L, Olson J, Paleologos N, Ryken T, Johnson T, Scullin E. Actr-54. Vigilant Observation Of Gliadel Wafer Implant (Vigilant) Registry: Interim Analysis Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.096  0.188
2021 Bhat K, Saki M, Cheng F, He L, Zhang L, Ioannidis A, Nathanson D, Tsang J, Bensinger SJ, Nghiemphu PL, Cloughesy TF, Liau LM, Kornblum HI, Pajonk F. Dopamine Receptor Antagonists, Radiation, and Cholesterol Biosynthesis in Mouse Models of Glioblastoma. Journal of the National Cancer Institute. PMID 33556960 DOI: 10.1093/jnci/djab018  0.187
2017 Chung LK, Pelargos PE, Chan AM, Demos JV, Lagman C, Sheppard JP, Nguyen T, Chang YL, Hojat SA, Prins RM, Liau LM, Nghiemphu L, Lai A, Cloughesy TF, Yong WH, et al. Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas. Brain Tumor Pathology. PMID 28887715 DOI: 10.1007/S10014-017-0300-1  0.186
2014 Woodworth DC, Pope WB, Liau LM, Kim HJ, Lai A, Nghiemphu PL, Cloughesy TF, Ellingson BM. Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastoma. Journal of Neuro-Oncology. 116: 551-8. PMID 24318915 DOI: 10.1007/s11060-013-1320-2  0.184
2011 Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, Phuphanich S, Black K, Peak S, Green RM, Spier CE, et al. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 142-8. PMID 21135282 DOI: 10.1200/Jco.2010.30.2729  0.182
2019 Chakhoyan A, Yao J, Leu K, Pope WB, Salamon N, Yong W, Lai A, Nghiemphu PL, Everson RG, Prins RM, Liau LM, Nathanson DA, Cloughesy TF, Ellingson BM. Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry. Scientific Reports. 9: 2846. PMID 30808879 DOI: 10.1038/S41598-018-37564-W  0.179
2003 Sehati N, Liau LM. Adjuvant Treatment for Gliomas Contemporary Neurosurgery. 25: 1-9. DOI: 10.1097/00029679-200307310-00001  0.179
2014 Avliyakulov NK, Rajavel KS, Le KM, Guo L, Mirsadraei L, Yong WH, Liau LM, Li S, Lai A, Nghiemphu PL, Cloughesy TF, Linetsky M, Haykinson MJ, Pope WB. C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma. Journal of Neuro-Oncology. 117: 53-65. PMID 24473683 DOI: 10.1007/S11060-014-1371-Z  0.178
2014 Zhukova N, Ramaswamy V, Remke M, Martin DC, Castelo-Branco P, Zhang CH, Fraser M, Tse K, Poon R, Shih DJ, Baskin B, Ray PN, Bouffet E, Dirks P, von Bueren AO, ... ... Liau LM, et al. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma. Acta Neuropathologica Communications. 2: 174. PMID 25539912 DOI: 10.1186/S40478-014-0174-Y  0.177
2019 Patel KS, Raymond C, Yao J, Tsung J, Liau LM, Everson R, Cloughesy TF, Ellingson B. Decorin Expression Is Associated With Diffusion MR Phenotypes in Glioblastoma Neurosurgery. 66. DOI: 10.1093/NEUROS/NYZ310_809  0.177
2023 Cho NS, Sanvito F, Thakuria S, Wang C, Hagiwara A, Nagaraj R, Oshima S, Lopez Kolkovsky AL, Lu J, Raymond C, Liau LM, Everson RG, Patel KS, Kim W, Yang I, et al. Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas. Journal of Neuro-Oncology. PMID 37294422 DOI: 10.1007/s11060-023-04363-x  0.176
2012 Park C-, Kim Y-, Kim JW, Kim TM, Choi SH, Kim YJ, Choi BS, Lee S-, Kim C-, Kim IH, Lee DZ, Kheder A, Forbes M, Craven I, Hadjivassiliou M, ... ... Liau L, et al. Clin-Neuro/Medical Oncology Neuro-Oncology. 14. DOI: 10.1093/Neuonc/Nos229  0.176
2018 Garrett M, Sperry J, Braas D, Yan W, Le TM, Mottahedeh J, Ludwig K, Eskin A, Qin Y, Levy R, Breunig JJ, Pajonk F, Graeber TG, Radu CG, Christofk H, ... ... Liau LM, et al. Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities. Cancer & Metabolism. 6: 4. PMID 29692895 DOI: 10.1186/S40170-018-0177-4  0.173
2017 Nghiemphu PL, Dezelan D, Tran JH, Cloughesy TF, Liau LM, Ahn C, White P. Improving care coordination for brain tumor patients through value-based care redesign of a virtual integrated practice unit. Journal of Clinical Oncology. 35: 110-110. DOI: 10.1200/JCO.2017.35.8_suppl.110  0.173
2019 Hu X, Matsumoto K, Jung RS, Weston TA, Heizer PJ, He C, Sandoval NP, Allan CM, Tu Y, Vinters HV, Liau LM, Ellison RM, Morales JE, Baufeld LJ, Bayley NA, et al. GPIHBP1 expression in gliomas promotes utilization of lipoprotein-derived nutrients. Elife. 8. PMID 31169500 DOI: 10.7554/Elife.47178  0.172
2020 Bhat K, Medina P, He L, Zhang L, Saki M, Ioannidis A, Nguyen NT, Sodhi SS, Sung D, Magyar CE, Liau LM, Kornblum HI, Pajonk F. 1-[(4-Nitrophenyl)sulfonyl]-4-phenylpiperazine Treatment After Brain Irradiation Preserves Cognitive Function in Mice. Neuro-Oncology. PMID 32291451 DOI: 10.1093/Neuonc/Noaa095  0.172
2012 Ellingson BM, Cloughesy TF, Zaw T, Lai A, Nghiemphu PL, Harris R, Lalezari S, Wagle N, Naeini KM, Carrillo J, Liau LM, Pope WB. Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma. Neuro-Oncology. 14: 333-43. PMID 22270220 DOI: 10.1093/neuonc/nor220  0.17
2022 Yao J, Hagiwara A, Oughourlian TC, Wang C, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study. Cancers. 14. PMID 35626127 DOI: 10.3390/cancers14102520  0.169
2013 Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, ... ... Liau LM, et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathologica. 126: 917-29. PMID 24174164 DOI: 10.1007/S00401-013-1198-2  0.168
2004 Yang I, Kremen TJ, Giovannone AJ, Paik E, Odesa SK, Prins RM, Liau LM. Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme. Journal of Neurosurgery. 100: 310-9. PMID 15086239 DOI: 10.3171/jns.2004.100.2.0310  0.167
2004 Wang Y, Zhu S, Cloughesy TF, Liau LM, Mischel PS. p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition. Oncogene. 23: 1283-90. PMID 14961077 DOI: 10.1038/sj.onc.1207244  0.167
2016 Harris RJ, Cloughesy TF, Liau LM, Nghiemphu PL, Lai A, Pope WB, Ellingson BM. Simulation, phantom validation, and clinical evaluation of fast pH-weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3 T. Nmr in Biomedicine. PMID 27717216 DOI: 10.1002/nbm.3611  0.167
2019 Liu LY, Ji MS, Nguyen NT, Chow FE, Molaie DM, Pianka ST, Green RM, Liau LM, Ellingson BM, Nghiemphu PL, Cloughesy TF, Lai A. Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series. Cns Oncology. CNS35. PMID 31293169 DOI: 10.2217/cns-2019-0007  0.165
2024 Zapanta Rinonos S, Li T, Pianka ST, Prins TJ, Eldred BSC, Kevan BM, Liau LM, Nghiemphu PL, Cloughesy TF, Lai A. dCas9/CRISPR-based methylation of O-6-methylguanine-DNA methyltransferase enhances chemosensitivity to temozolomide in malignant glioma. Journal of Neuro-Oncology. PMID 38224404 DOI: 10.1007/s11060-023-04531-z  0.164
2001 Catania MG, Johnson MW, Liau LM, Kremen TJ, deVellis JS, Vinters HV. Hamartin expression and interaction with tuberin in tumor cell lines and primary cultures. Journal of Neuroscience Research. 63: 276-83. PMID 11170177 DOI: 10.1002/1097-4547(20010201)63:3<276::Aid-Jnr1021>3.0.Co;2-A  0.164
2017 Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, Gröbner S, Segura-Wang M, Zichner T, Rudneva VA, Warnatz HJ, Sidiropoulos N, Phillips AH, Schumacher S, Kleinheinz K, ... ... Liau LM, et al. The whole-genome landscape of medulloblastoma subtypes. Nature. 547: 311-317. PMID 28726821 DOI: 10.1038/Nature22973  0.163
2010 Cohen JR, Resnick DZ, Niewiadomski P, Dong H, Liau LM, Waschek JA. Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures. Bmc Cancer. 10: 676. PMID 21143927 DOI: 10.1186/1471-2407-10-676  0.162
2008 Pope WB, Chen JH, Dong J, Carlson MR, Perlina A, Cloughesy TF, Liau LM, Mischel PS, Nghiemphu P, Lai A, Nelson SF. Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. Radiology. 249: 268-77. PMID 18796682 DOI: 10.1148/radiol.2491072000  0.161
2010 Liau LM. Comment Neurosurgery. 66: 156-157. DOI: 10.1227/01.Neu.0000363149.58885.2E  0.157
2023 Liu V, Wetzel EA, Eldred BSC, Zapanta Rinonos S, Prins TJ, Khanlou N, Liau LM, Chong R, Nghiemphu PL, Cloughesy TF, Ellingson BM, Lai A. A single-institution retrospective analysis of pathologically determined malignant transformation in mutant glioma patients. Neuro-Oncology Advances. 5: vdad036. PMID 37152809 DOI: 10.1093/noajnl/vdad036  0.154
2020 Bhat K, Saki M, Vlashi E, Cheng F, Duhachek-Muggy S, Alli C, Yu G, Medina P, He L, Damoiseaux R, Pellegrini M, Zemke NR, Nghiemphu PL, Cloughesy TF, Liau LM, et al. The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 32358191 DOI: 10.1073/Pnas.1920154117  0.153
2017 Brown TJ, Bota DA, Maher EA, Aregawi DG, Liau LM, Brown PD, Buckner JC, Weller M, Van Den Bent MJ, Berger MS, Glantz MJ. Association of aggressive resection with survival and progression-free survival in adult low-grade glioma: A systematic review and meta-analysis with numbers needed to treat. Journal of Clinical Oncology. 35: 2025-2025. DOI: 10.1200/Jco.2017.35.15_Suppl.2025  0.153
2007 Kim W, Prins RM, Liau LM. EPIGENETIC MODIFICATIONS OF CANCER ANTIGEN EXPRESSION IN GLIOMAS. Journal of Investigative Medicine. 55: S121. DOI: 10.1097/00042871-200701010-00284  0.153
2011 Sun S, Wang Q, Giang A, Cheng C, Soo C, Wang CY, Liau LM, Chiu R. Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-κB. Journal of Neuro-Oncology. 101: 1-14. PMID 20454998 DOI: 10.1007/s11060-010-0220-y  0.152
2020 Patel KS, Everson RG, Yao J, Raymond C, Goldman J, Schlossman J, Tsung J, Tan C, Pope WB, Ji MS, Nguyen NT, Lai A, Nghiemphu PL, Liau LM, Cloughesy TF, et al. Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden. Neurosurgery. PMID 32365185 DOI: 10.1093/neuros/nyaa135  0.151
2003 Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, Mischel PS, Nelson SF. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene. 22: 4918-23. PMID 12894235 DOI: 10.1038/sj.onc.1206753  0.151
2017 Leu K, Ott GA, Lai A, Nghiemphu PL, Pope WB, Yong WH, Liau LM, Cloughesy TF, Ellingson BM. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas. Journal of Neuro-Oncology. PMID 28547590 DOI: 10.1007/S11060-017-2506-9  0.148
2014 Piccioni DE, Selfridge J, Mody RR, Chowdhury R, Li S, Lalezari S, Wawrzynski J, Quan J, Zurayk M, Chou AP, Sanchez DE, Liau LM, Ellingson BM, Pope WB, Nghiemphu PL, et al. Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. Neuro-Oncology. 16: 815-22. PMID 24627236 DOI: 10.1093/Neuonc/Nou028  0.147
2012 Garrett MC, Pouratian N, Liau LM. Use of language mapping to aid in resection of gliomas in eloquent brain regions. Neurosurgery Clinics of North America. 23: 497-506. PMID 22748661 DOI: 10.1016/J.Nec.2012.05.003  0.146
2016 Nguyen HN, Li T, Lie A, Ozer BH, Chowdhury R, Liu F, Wei B, Wang H, Elashoff RM, Liau LM, Yong WH, Ellingson BM, Nghiemphu PL, Cloughesy TF, Lai A. Benefit of MGMT methylation in glioblastoma in relation to hTERT promoter mutation. Journal of Clinical Oncology. 34: 2006-2006. DOI: 10.1200/Jco.2016.34.15_Suppl.2006  0.146
2012 Northcott PA, Shih DJ, Peacock J, Garzia L, Morrissy AS, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE, Beroukhim R, Ellison DW, Marshall CR, Lionel AC, Mack S, ... ... Liau LM, et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature. 488: 49-56. PMID 22832581 DOI: 10.1038/Nature11327  0.145
2015 Harris RJ, Cloughesy TF, Hardy AJ, Liau LM, Pope WB, Nghiemphu PL, Lai A, Ellingson BM. MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab. Journal of Neuro-Oncology. 122: 497-505. PMID 25773062 DOI: 10.1007/s11060-015-1755-8  0.145
2020 Yao J, Hagiwara A, Raymond C, Shabani S, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study. Scientific Reports. 10: 11922. PMID 32681084 DOI: 10.1038/s41598-020-68733-5  0.145
2011 Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB. High order diffusion tensor imaging in human glioblastoma. Academic Radiology. 18: 947-54. PMID 21536466 DOI: 10.1016/j.acra.2011.02.020  0.144
2006 Liau LM. Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas: Commentary Neurosurgery. 59: 909-910. DOI: 10.1227/01.NEU.0000233907.03070.7B  0.144
2020 Tatekawa H, Hagiwara A, Yao J, Oughourlian TC, Ueda I, Uetani H, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. Voxel-Wise and Patient-Wise Correlation of F-FDOPA PET, rCBV, and ADC in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32646876 DOI: 10.2967/jnumed.120.247411  0.143
2019 Yao J, Tan CHP, Schlossman J, Chakhoyan A, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma. Journal of Neuro-Oncology. PMID 30806888 DOI: 10.1007/s11060-019-03132-z  0.143
2009 Chang EF, Clark A, Jensen RL, Bernstein M, Guha A, Carrabba G, Mukhopadhyay D, Kim W, Liau LM, Chang SM, Smith JS, Berger MS, McDermott MW. Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. Journal of Neurosurgery. 111: 203-10. PMID 19267536 DOI: 10.3171/2009.2.JNS081101  0.137
2008 Lee Y, Scheck AC, Cloughesy TF, Lai A, Dong J, Farooqi HK, Liau LM, Horvath S, Mischel PS, Nelson SF. Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age. Bmc Medical Genomics. 1: 52. PMID 18940004 DOI: 10.1186/1755-8794-1-52  0.135
2013 Mareninov S, De Jesus J, Sanchez DE, Kay AB, Wilson RW, Babic I, Chen W, Telesca D, Lou JJ, Mirsadraei L, Gardner TP, Khanlou N, Vinters HV, Shafa BB, Lai A, ... Liau LM, et al. Lyophilized brain tumor specimens can be used for histologic, nucleic acid, and protein analyses after 1 year of room temperature storage. Journal of Neuro-Oncology. 113: 365-73. PMID 23640138 DOI: 10.1007/S11060-013-1135-1  0.135
2020 Patel KS, Kejriwal S, Thammachantha S, Duong C, Murillo A, Gordon LK, Cloughesy TF, Liau L, Yong W, Yang I, Wadehra M. Increased epithelial membrane protein 2 expression in glioblastoma after treatment with bevacizumab. Neuro-Oncology Advances. 2: vdaa112. PMID 33063013 DOI: 10.1093/noajnl/vdaa112  0.135
2009 Liau LM. Adjuvant treatment with locally delivered oncogel delays the onset of paresis after surgical resection of experimental spinal column metastasis: Commentary Neurosurgery. 65: 200. DOI: 10.1227/01.Neu.0000345948.54008.82  0.133
2008 Lai A, Filka E, McGibbon B, Nghiemphu PL, Graham C, Yong WH, Mischel P, Liau LM, Bergsneider M, Pope W, Selch M, Cloughesy T. Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability. International Journal of Radiation Oncology, Biology, Physics. 71: 1372-80. PMID 18355978 DOI: 10.1016/J.Ijrobp.2007.11.068  0.133
2019 Brown TJ, Bota DA, van Den Bent MJ, Brown PD, Maher E, Aregawi D, Liau LM, Buckner JC, Weller M, Berger MS, Glantz M. Management of low-grade glioma: a systematic review and meta-analysis. Neuro-Oncology Practice. 6: 249-258. PMID 31386075 DOI: 10.1093/Nop/Npy034  0.133
2020 Tatekawa H, Yao J, Oughourlian TC, Hagiwara A, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Salamon N, Ellingson BM. Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study. Clinical Nuclear Medicine. PMID 33031233 DOI: 10.1097/RLU.0000000000003318  0.131
2005 Bergsneider M, Sehati N, Villablanca P, McArthur DL, Becker DP, Liau LM. Mahaley Clinical Research Award: extent of glioma resection using low-field (0.2 T) versus high-field (1.5 T) intraoperative MRI and image-guided frameless neuronavigation. Clinical Neurosurgery. 52: 389-99. PMID 16626099  0.13
2009 Nghiemphu PL, Liu W, Lee Y, Than T, Graham C, Lai A, Green RM, Pope WB, Liau LM, Mischel PS, Nelson SF, Elashoff R, Cloughesy TF. Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience. Neurology. 72: 1217-22. PMID 19349600 DOI: 10.1212/01.Wnl.0000345668.03039.90  0.129
2022 Krawczyk MC, Haney JR, Pan L, Caneda C, Khankan RR, Reyes SD, Chang JW, Morselli M, Vinters HV, Wang AC, Cobos I, Gandal MJ, Bergsneider M, Kim W, Liau LM, et al. Human Astrocytes Exhibit Tumor Microenvironment-, Age-, and Sex-Related Transcriptomic Signatures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34987109 DOI: 10.1523/JNEUROSCI.0407-21.2021  0.127
2020 Oughourlian TC, Yao J, Hagiwara A, Nathanson DA, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas. Neuroradiology. PMID 33106922 DOI: 10.1007/s00234-020-02585-8  0.127
2013 Lalezari S, Chou AP, Tran A, Solis OE, Khanlou N, Chen W, Li S, Carrillo JA, Chowdhury R, Selfridge J, Sanchez DE, Wilson RW, Zurayk M, Lalezari J, Lou JJ, ... ... Liau LM, et al. Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome. Neuro-Oncology. 15: 370-81. PMID 23328811 DOI: 10.1093/Neuonc/Nos308  0.127
2016 Leu K, Boxerman JL, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB, Ellingson BM. Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange. Ajnr. American Journal of Neuroradiology. PMID 27079371 DOI: 10.3174/ajnr.A4759  0.126
2018 Li T, Cox CD, Ozer B, Nguyen NT, Nguyen HN, Lai TJ, Li S, Liu F, Kornblum HI, Liau LM, Nghiemphu PL, Cloughesy TF, Lai A. D-2-Hydroxyglutarate is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-induced MIR148A Promoter Methylation. Molecular Cancer Research : McR. PMID 29545476 DOI: 10.1158/1541-7786.MCR-17-0367  0.126
2022 Goldman J, Hagiwara A, Yao J, Raymond C, Ong C, Bakhti R, Kwon E, Farhat M, Torres C, Erickson LG, Curl BJ, Lee M, Pope WB, Salamon N, Nghiemphu PL, ... ... Liau LM, et al. Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease. Frontiers in Oncology. 12: 849993. PMID 35371980 DOI: 10.3389/fonc.2022.849993  0.126
2018 Kong XT, Nguyen NT, Choi YJ, Zhang G, Nguyen HN, Filka E, Green S, Yong WH, Liau LM, Green RM, Kaprealian T, Pope WB, Nghiemphu PL, Cloughesy T, Lassman A, et al. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. International Journal of Radiation Oncology, Biology, Physics. 100: 1195-1203. PMID 29722661 DOI: 10.1016/J.Ijrobp.2018.01.001  0.123
2014 Shih DJ, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM, Garzia L, Peacock J, Mack SC, Wu X, Rolider A, ... ... Liau LM, et al. Cytogenetic prognostication within medulloblastoma subgroups. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 886-96. PMID 24493713 DOI: 10.1200/Jco.2013.50.9539  0.12
2006 Liau LM. Surgical Neurology. 66: 331. DOI: 10.1016/j.surneu.2006.06.042  0.12
2003 Broder H, Anderson A, Kremen TJ, Odesa SK, Liau LM. Journal of Neuro-Oncology. 64: 21-30. DOI: 10.1023/A:1024921506081  0.12
2024 Pianka ST, Li T, Prins TJ, Eldred BSC, Kevan BM, Liang H, Zapanta Rinonos S, Kornblum HI, Nathanson DA, Pellegrini M, Liau LM, Nghiemphu PL, Cloughesy TF, Lai A. D-2-HG Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation. Cancer Research Communications. PMID 38445960 DOI: 10.1158/2767-9764.CRC-23-0271  0.12
2006 Lee JC, Vivanco I, Beroukhim R, Huang JH, Feng WL, DeBiasi RM, Yoshimoto K, King JC, Nghiemphu P, Yuza Y, Xu Q, Greulich H, Thomas RK, Paez JG, Peck TC, ... ... Liau LM, et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. Plos Medicine. 3: e485. PMID 17177598 DOI: 10.1371/Journal.Pmed.0030485  0.118
2017 Brown TJ, Bota DA, Maher EA, Aregawi DG, Liau LM, Brown PD, Buckner JC, Weller M, Van Den Bent MJ, Berger MS, Glantz MJ. Quantifying the benefit of chemotherapy and radiation in low-grade glioma: A systematic review and meta-analysis of numbers needed to treat. Journal of Clinical Oncology. 35: 2057-2057. DOI: 10.1200/Jco.2017.35.15_Suppl.2057  0.118
2016 Nguyen HN, Lie A, Li T, Chowdhury R, Liu F, Ozer B, Wei B, Green RM, Ellingson BM, Wang HJ, Elashoff R, Liau LM, Yong WH, Nghiemphu PL, Cloughesy T, et al. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy. Neuro-Oncology. PMID 27571882 DOI: 10.1093/Neuonc/Now189  0.117
2019 Yao J, Chakhoyan A, Nathanson DA, Yong WH, Salamon N, Raymond C, Mareninov S, Lai A, Nghiemphu PL, Prins RM, Pope WB, Everson RG, Liau LM, Cloughesy TF, Ellingson BM. Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. Neuro-Oncology. PMID 31066901 DOI: 10.1093/Neuonc/Noz078  0.116
2022 Lam K, Eldred BSC, Kevan B, Pianka S, Eldred BA, Zapanta Rinonos S, Yong WH, Liau LM, Nghiemphu PL, Cloughesy TF, Green RM, Lai A. Prognostic value of -methylguanine-DNA methyltransferase methylation in isocitrate dehydrogenase mutant gliomas. Neuro-Oncology Advances. 4: vdac030. PMID 35386566 DOI: 10.1093/noajnl/vdac030  0.115
2009 Du J, Bernasconi P, Clauser KR, Mani DR, Finn SP, Beroukhim R, Burns M, Julian B, Peng XP, Hieronymus H, Maglathlin RL, Lewis TA, Liau LM, Nghiemphu P, Mellinghoff IK, et al. Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nature Biotechnology. 27: 77-83. PMID 19098899 DOI: 10.1038/Nbt.1513  0.114
2006 Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, Mischel PS, Nelson SF. Erratum: Gene expression profiling identifies molecular subtypes of gliomas Oncogene. 25: 4256-4256. DOI: 10.1038/sj.onc.1209746  0.11
2012 Hickey MJ, Malone CC, Erickson KE, Gomez GG, Young EL, Liau LM, Prins RM, Kruse CA. Implementing preclinical study findings to protocol design: Translational studies with alloreactive CTL for gliomas American Journal of Translational Research. 4: 114-126.  0.109
2005 Nabhani T, Liau LM. Neurosurgical and Other Treatment Options for Metastatic Melanoma in the Central Nervous System Contemporary Neurosurgery. 27: 1-5. DOI: 10.1097/00029679-200506150-00001  0.108
2008 Liau LM. Angiogenesis and gliomas: Current issues and development of surrogate markers - Commentary Neurosurgery. 62: 51. DOI: 10.1227/01.NEU.0000311060.65002.4E  0.107
2021 Hagiwara A, Yao J, Raymond C, Cho NS, Everson R, Patel K, Morrow DH, Desousa BR, Mareninov S, Chun S, Nathanson DA, Yong WH, Andrei G, Divakaruni AS, Salamon N, ... ... Liau LM, et al. "Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging. Neuroimage. Clinical. 32: 102882. PMID 34911188 DOI: 10.1016/j.nicl.2021.102882  0.107
2018 Yao J, Ruan D, Raymond C, Liau LM, Salamon N, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. Improving B Correction for pH-Weighted Amine Proton Chemical Exchange Saturation Transfer (CEST) Imaging by Use of k-Means Clustering and Lorentzian Estimation. Tomography (Ann Arbor, Mich.). 4: 123-137. PMID 30320212 DOI: 10.18383/j.tom.2018.00017  0.107
2009 Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 462: 739-44. PMID 19935646 DOI: 10.1038/Nature08617  0.106
2021 Coltin H, Sundaresan L, Smith KS, Skowron P, Massimi L, Eberhart CG, Schreck KC, Gupta N, Weiss WA, Tirapelli D, Carlotti C, Li KKW, Ryzhova M, Golanov A, Zheludkova O, ... ... Liau LM, et al. Subgroup and subtype-specific outcomes in adult medulloblastoma. Acta Neuropathologica. PMID 34409497 DOI: 10.1007/s00401-021-02358-4  0.105
2021 Tatekawa H, Hagiwara A, Uetani H, Bahri S, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET. Cancer Imaging : the Official Publication of the International Cancer Imaging Society. 21: 27. PMID 33691798 DOI: 10.1186/s40644-021-00396-5  0.104
2011 Lai A, Lalezari S, Chou AP, Tran A, Solis OE, Carrillo JA, Chen W, Mischel PS, Green RM, Nghiemphu PL, Liau LM, Wang H, Elashoff RM, Cloughesy TF, Yong WH. Prediction of GBM outcome using combined analysis of MGMT protein expression and promoter methylation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2003. PMID 28023883 DOI: 10.1200/Jco.2011.29.15_Suppl.2003  0.104
2007 Liau LM. Effects of drug efflux on convection-enhanced paclitaxel delivery to malignant gliomas: Technical note - Commentary Neurosurgery. 61: E882. DOI: 10.1227/01.NEU.0000298922.77921.F2  0.102
2009 Liau LM. Human leukocyte antigen frequency in human high-grade gliomas: A case-control study in sicily - Commentary Neurosurgery. 64: 1089. DOI: 10.1227/01.NEU.0000345946.35786.92  0.1
2017 Movassaghi M, Shabihkhani M, Hojat SA, Williams RR, Chung LK, Im K, Lucey GM, Wei B, Mareninov S, Wang MW, Ng DW, Tashjian RS, Magaki S, Perez-Rosendahl M, Yang I, ... ... Liau LM, et al. Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats. Experimental and Molecular Pathology. PMID 28663030 DOI: 10.1016/J.Yexmp.2017.06.006  0.099
2020 Muftuoglu Y, Liau LM. Results From the CheckMate 143 Clinical Trial: Stalemate or New Game Strategy for Glioblastoma Immunotherapy? Jama Oncology. PMID 32437542 DOI: 10.1001/jamaoncol.2020.0857  0.098
2003 Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF, Nelson SF. Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene. 22: 2361-73. PMID 12700671 DOI: 10.1038/sj.onc.1206344  0.098
2008 Liau LM. Targeting the α1 subunit of the sodium pump to combat glioblastoma cells - Commentary Neurosurgery. 62: 221. DOI: 10.1227/01.NEU.0000311080.43024.0E  0.098
2012 Pollack IF, Jakacki RI, Butterfield L, Okada H, Chiba Y, Hashimoto N, Kagawa N, Kinoshita M, Kijima N, Hirayama R, Oji Y, Tsuboi A, Oka Y, Sugiyama H, Yoshimine T, ... ... Liau LM, et al. CLIN-IMMUNOTHERAPY/BIOLOGIC THERAPIES Neuro-Oncology. 14: vi43-vi49. DOI: 10.1093/Neuonc/Nos224  0.098
2023 Sanvito F, Raymond C, Cho NS, Yao J, Hagiwara A, Orpilla J, Liau LM, Everson RG, Nghiemphu PL, Lai A, Prins R, Salamon N, Cloughesy TF, Ellingson BM. Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI. European Radiology. PMID 37882836 DOI: 10.1007/s00330-023-10215-z  0.096
2018 Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, et al. Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. Journal of Translational Medicine. 16: 179. PMID 29958537 DOI: 10.1186/S12967-018-1552-1  0.093
2010 Vivanco I, Rohle D, Versele M, Iwanami A, Kuga D, Oldrini B, Tanaka K, Dang J, Kubek S, Palaskas N, Hsueh T, Evans M, Mulholland D, Wolle D, Rajasekaran S, ... ... Liau LM, et al. The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation. Proceedings of the National Academy of Sciences of the United States of America. 107: 6459-64. PMID 20308550 DOI: 10.1073/Pnas.0911188107  0.09
2017 Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, ... ... Liau LM, et al. Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 31: 737-754.e6. PMID 28609654 DOI: 10.1016/J.Ccell.2017.05.005  0.089
2018 Harris RJ, Yao J, Chakhoyan A, Raymond C, Leu K, Liau LM, Nghiemphu PL, Lai A, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI). Magnetic Resonance in Medicine. PMID 29626359 DOI: 10.1002/mrm.27204  0.089
2018 Babu MA, Liau LM, Connolly ES, Meyer FB. Maintenance of Certification: Perceptions and Attitudes of Neurosurgeons. Neurosurgery. PMID 29438528 DOI: 10.1093/Neuros/Nyx498  0.087
2009 Liau LM. Anatomic compression caused by high-volume convection-enhanced delivery to the brain: Commentary Neurosurgery. 65: 586. DOI: 10.1227/01.NEU.0000350229.77462.2F  0.087
2021 Pan Y, Hysinger JD, Barron T, Schindler NF, Cobb O, Guo X, Yalçın B, Anastasaki C, Mulinyawe SB, Ponnuswami A, Scheaffer S, Ma Y, Chang KC, Xia X, Toonen JA, ... ... Liau LM, et al. NF1 mutation drives neuronal activity-dependent initiation of optic glioma. Nature. PMID 34040258 DOI: 10.1038/s41586-021-03580-6  0.086
2018 Chakhoyan A, Woodworth DC, Harris RJ, Lai A, Nghiemphu PL, Liau LM, Pope WB, Cloughesy TF, Ellingson BM. Mono-exponential, diffusion kurtosis and stretched exponential diffusion MR imaging response to chemoradiation in newly diagnosed glioblastoma. Journal of Neuro-Oncology. PMID 29855771 DOI: 10.1007/s11060-018-2910-9  0.086
2017 Shabihkhani M, Telesca D, Movassaghi M, Naeini YB, Naeini KM, Hojat SA, Gupta D, Lucey GM, Ontiveros M, Wang MW, Hanna LS, Sanchez DE, Mareninov S, Khanlou N, Vinters HV, ... ... Liau LM, et al. Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma. Journal of Neuro-Oncology. PMID 28161760 DOI: 10.1007/S11060-017-2377-0  0.084
2023 Liau LM, Ashkan K, Bosch ML. External Control Arms and Data Analysis Methods in Nonrandomized Trial of Patients With Glioblastoma-Reply. Jama Oncology. PMID 37200017 DOI: 10.1001/jamaoncol.2023.1072  0.078
2017 Brown TJ, Bota D, Maher E, Aregawi D, Liau LM, Buckner J, Weller M, van den Bent MJ, Berger MS, Glantz M. P10.03 Management of low-grade glioma: a systematic review and meta-analysis Neuro-Oncology. 19: iii85-iii85. DOI: 10.1093/neuonc/nox036.321  0.078
2021 Sharaf R, Pavlick DC, Frampton GM, Cooper M, Jenkins J, Danziger N, Haberberger J, Alexander BM, Cloughesy T, Yong WH, Liau LM, Nghiemphu PL, Ji M, Lai A, Ramkissoon SH, et al. Erratum to: FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas. Neuro-Oncology Advances. 3: vdab059. PMID 34169283 DOI: 10.1093/noajnl/vdab059  0.078
2022 Shidoh S, Savjani RR, Cho NS, Ullman HE, Hagiwara A, Raymond C, Lai A, Nghiemphu PL, Liau LM, Pope WB, Cloughesy TF, Kaprealian TB, Salamon N, Ellingson BM. Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation. Journal of Neuro-Oncology. PMID 36053452 DOI: 10.1007/s11060-022-04123-3  0.078
2013 Aaberg-Jessen C, Fogh L, Halle B, Jensen V, Brunner N, Kristensen BW, Abe T, Momii Y, Watanabe J, Morisaki I, Natsume A, Wakabayashi T, Fujiki M, Aldaz B, Fabius AWM, ... ... Liau L, et al. EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 15: iii37-iii61. DOI: 10.1093/Neuonc/Not176  0.078
2006 Salgaller ML, Liau LM. Current status of clinical trials for glioblastoma. Reviews On Recent Clinical Trials. 1: 265-81. PMID 18473979  0.076
2016 Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K, Remke M, Mynarek M, Rutkowski S, Gururangan S, McLendon RE, ... ... Liau LM, et al. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27269943 DOI: 10.1200/Jco.2015.65.7825  0.074
2021 Liau LM. Glioblastoma: Molecular Mechanisms and Clinical Trials. Neurosurgery Clinics of North America. 32: xiii. PMID 33781510 DOI: 10.1016/j.nec.2021.03.001  0.073
2012 Vivanco I, Robins HI, Rohle D, Campos C, Grommes C, Nghiemphu PL, Kubek S, Oldrini B, Chheda MG, Yannuzzi N, Tao H, Zhu S, Iwanami A, Kuga D, Dang J, ... ... Liau LM, et al. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discovery. 2: 458-71. PMID 22588883 DOI: 10.1158/2159-8290.Cd-11-0284  0.072
2015 Heaney AP, Sumerel B, Rajalingam R, Bergsneider M, Yong WH, Liau LM. HLA Markers DQ8 and DR53 Are Associated With Lymphocytic Hypophysitis and May Aid in Differential Diagnosis. The Journal of Clinical Endocrinology and Metabolism. 100: 4092-7. PMID 26317559 DOI: 10.1210/Jc.2015-2702  0.07
2018 Bergsneider BH, Liau LM. Next-Generation Sequencing and Personalized Medicine for Brain Cancer Current Surgery Reports. 6. DOI: 10.1007/s40137-018-0221-x  0.07
2018 Lagman C, Sheppard JP, Romiyo P, Nguyen T, Prashant GN, Nagasawa DT, Liau LM, Yang I. Risk factors for platelet transfusion in glioblastoma surgery. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 29452964 DOI: 10.1016/j.jocn.2018.01.072  0.07
2013 Williams KJ, Argus JP, Zhu Y, Wilks MQ, Marbois BN, York AG, Kidani Y, Pourzia AL, Akhavan D, Lisiero DN, Komisopoulou E, Henkin AH, Soto H, Chamberlain BT, Vergnes L, ... ... Liau LM, et al. An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. Cancer Research. 73: 2850-62. PMID 23440422 DOI: 10.1158/0008-5472.Can-13-0382-T  0.069
2017 Babu MA, Liau LM, Meyer FB. Recognized focused practice: Does sub-specialty designation offer value to the neurosurgeon? Plos One. 12: e0189105. PMID 29240838 DOI: 10.1371/Journal.Pone.0189105  0.068
2007 Liau LM. Clinical significance of ABCA2, a possible molecular marker for oligodendrogliomas: Commentary Neurosurgery. 60: 714. DOI: 10.1227/01.NEU.0000255395.15657.06  0.066
2007 Thomas RK, Baker AC, DeBiasi RM, Winckler W, LaFramboise T, Lin WM, Wang M, Feng W, Zander T, MacConnaill LE, Lee JC, Nicoletti R, Hatton C, Goyette M, Girard L, ... ... Liau LM, et al. Erratum: Corrigendum: High-throughput oncogene mutation profiling in human cancer Nature Genetics. 39: 567-567. DOI: 10.1038/Ng0407-567A  0.065
2016 Abdaljaleel M, Mazumder R, Patel CB, Im K, Pope W, Liau LM, Vinters HV, Yong WH. Multiple calcifying pseudoneoplasms of the neuraxis (MCAPNON): Distinct entity, CAPNON variant, or old neurocysticercosis? Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 27862397 DOI: 10.1111/Neup.12349  0.064
2007 Chen CC, Liau LCK, Jung GB, Chan SH. Composition effects in YSZ electrolyte tapes for solid oxide fuel cells fabricated by tape casting Ecs Transactions. 7: 2161-2165. DOI: 10.1149/1.2729331  0.061
2010 Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 465: 966. PMID 20559394 DOI: 10.1038/nature09132  0.06
2009 Liau LM. Direct intratumoral chemotherapy with carboplatin and epinephrine in a recurrent cervical chordoma: Case report - Commentary Neurosurgery. 65: E630. DOI: 10.1227/01.NEU.0000350864.78326.14  0.059
2008 Liau LCK, Chiang KL, Dai WW, Chung YC. Effects of spherical titania particle electrodes on dye-sensitized solar cells Conference Record of the Ieee Photovoltaic Specialists Conference. DOI: 10.1109/PVSC.2008.4922659  0.058
2016 Laks DR, Crisman TJ, Shih MY, Mottahedeh J, Gao F, Sperry J, Garrett MC, Yong WH, Cloughesy TF, Liau LM, Lai A, Coppola G, Kornblum HI. Large-scale assessment of the gliomasphere model system. Neuro-Oncology. PMID 27116978 DOI: 10.1093/Neuonc/Now045  0.057
2020 Wang MC, Boop FA, Kondziolka D, Resnick DK, Kalkanis SN, Koehnen E, Selden NR, Heilman CB, Valadka AB, Cockroft KM, Wilson JA, Ellenbogen RG, Asher AL, Byrne RW, Camarata PJ, ... ... Liau LM, et al. Continuous improvement in patient safety and quality in neurological surgery: the American Board of Neurological Surgery in the past, present, and future. Journal of Neurosurgery. 1-7. PMID 33065539 DOI: 10.3171/2020.6.JNS202066  0.051
1991 Liau LM, Sleight AJ, Pitha J, Peroutka SJ. Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist. Pharmacology, Biochemistry, and Behavior. 38: 555-9. PMID 1648748 DOI: 10.1016/0091-3057(91)90013-R  0.048
2009 Liau LCK, Wu RK. Optimal control of the sintering strain rate of yttria-stabilized zirconia electrolytes for solid oxide fuel cells using a thermal-mechanical analyzer during the sintering process Industrial and Engineering Chemistry Research. 48: 7567-7573. DOI: 10.1021/ie801435e  0.045
2016 Babu MA, Liau LM, Spinner RJ, Meyer FB. 325 Maintenance of Certification and the Aging Neurosurgeon. Neurosurgery. 63: 194-5. PMID 27399523 DOI: 10.1227/01.Neu.0000489814.98347.Ee  0.044
2008 Liau LM. Limitations of diffusion-weighted imaging in the diagnosis of postoperative infections: Commentary Neurosurgery. 62: 582. DOI: 10.1227/01.NEU.0000311349.25281.BD  0.042
2021 Air EL, Orrico KO, Benzil DL, Scarrow AM, Bean JR, Mazzola CA, Liau LM, Rutka JT, Muraszko KM. Developing a professionalism and harassment policy for organized neurosurgery. Journal of Neurosurgery. 1-2. PMID 33761456 DOI: 10.3171/2021.1.JNS218000  0.042
2021 Air EL, Orrico KO, Benzil DL, Scarrow AM, Bean JR, Mazzola CA, Liau LM, Rutka JT, Muraszko KM. Developing a Professionalism and Harassment Policy for Organized Neurosurgery. Neurosurgery. PMID 33755153 DOI: 10.1093/neuros/nyab051  0.04
2008 Liau LCK, Chang H, Yang TCK, Huang CL. Effect of poly(ethylene glycol) additives on the photocatalytic activity of TiO2 films prepared by sol-gel processing and low temperature treatments Journal of the Chinese Institute of Chemical Engineers. 39: 237-242. DOI: 10.1016/j.jcice.2007.12.014  0.037
2015 Liau LCK, Tseng PC. Effect of Current Pulse on Electronic Properties of Cu2O Films Fabricated by Electrochemical Deposition Process Electrochimica Acta. 182: 781-788. DOI: 10.1016/j.electacta.2015.09.166  0.036
2022 Rallo MS, Strong MJ, Teton ZE, Murazsko K, Nanda A, Liau L, Rosseau G. Targeted Public Health Training for Neurosurgeons: An Essential Task for the Prioritization of Neurosurgery in the Evolving Global Health Landscape. Neurosurgery. 92: 10-17. PMID 36519856 DOI: 10.1227/neu.0000000000002169  0.036
2022 Wang A, Shlobin NA, DiCesare JAT, Holly LT, Liau LM. Diversity in Neurosurgical Recruitment and Training in the United States: A Systematic Review. World Neurosurgery. PMID 35339710 DOI: 10.1016/j.wneu.2022.03.086  0.031
2008 Liau LM. Usefulness of intraoperative photodynamic diagnosis using 5-aminolevulinic acid for meningiomas with cranial invasion: Technical case report - Commentary Neurosurgery. 62: ONSE103. DOI: 10.1227/01.neu.0000317378.22820.46  0.031
2023 Charles AJ, Seas A, Corley J, Duvall JB, Owolo E, Abu-Bonsrah N, Elsamadicy AA, Simpson V, Sanusi O, Holly LT, Rodriguez A, Nduom EK, Levi AD, Liau LM, Quiñones-Hinojosa A, et al. Promoting diversity in neurosurgery through a virtual symposium. Journal of Neurosurgery. 1-8. PMID 36905659 DOI: 10.3171/2023.1.JNS221743  0.026
2013 Liau LCK, Chen YP. Effects of voltage operating strategy on electrophoretic self-assembly deposition of spherical SiO2 particles in water Colloids and Surfaces a: Physicochemical and Engineering Aspects. 429: 121-128. DOI: 10.1016/j.colsurfa.2013.03.066  0.025
2021 Thum JA, Chang D, Tata N, Liau LM. Neurosurgeons in 2020: the impact of gender on neurosurgical training, family planning, and workplace culture. Neurosurgical Focus. 50: E11. PMID 33789233 DOI: 10.3171/2020.12.FOCUS20965  0.023
2012 Liau LCK, Kuo JW, Chiang HN. Design and fabrication of ZnO/TiO2-based thin-film inverter circuits using solution processing techniques Semiconductor Science and Technology. 27. DOI: 10.1088/0268-1242/27/12/125012  0.021
2013 Liau LCK, Lin YC, Peng YJ. Fabrication pathways of p-n Cu2O homojunction films by electrochemical deposition processing Journal of Physical Chemistry C. 117: 26426-26431. DOI: 10.1021/jp405715c  0.016
2015 Liau LCK, Lai GB, Juang RC, Chang BH, Yang TCK. Preparation of Ag/SiO2 near-infrared absorbers using the combination of sputtering and spin-coating depositions Thin Solid Films. 578: 63-68. DOI: 10.1016/j.tsf.2015.02.024  0.016
2017 Babu MA, Liau LM, Spinner RJ, Meyer FB. The Aging Neurosurgeon: When Is Enough, Enough? Attitudes Toward Ceasing Practice and Testing in Late Career. Mayo Clinic Proceedings. PMID 29153596 DOI: 10.1016/j.mayocp.2017.09.004  0.015
2007 Liau LCK, Chiang PI. Stability evaluation of UV-exposure on multiple dye/nano-TiO2 layers Conference Record of the 2006 Ieee 4th World Conference On Photovoltaic Energy Conversion, Wcpec-4. 2: 1540-1543. DOI: 10.1109/WCPEC.2006.279777  0.015
2006 Liau LCK, Chien YC. Kinetic investigation of ZrO2, Y2O3, and Ni on poly(vinyl butyral) thermal degradation using nonlinear heating functions Journal of Applied Polymer Science. 102: 2552-2559. DOI: 10.1002/app.24683  0.011
2008 Liau LCK, Lin CC. Semiconductor characterization of Cr3+-doped titania electrodes with p-n homojunction devices Thin Solid Films. 516: 1998-2002. DOI: 10.1016/j.tsf.2007.06.025  0.011
2020 Kondziolka D, Liau LM. Editorial. Sexual harassment in neurosurgery: #UsToo. Journal of Neurosurgery. 1-3. PMID 33171437 DOI: 10.3171/2020.8.JNS202583  0.01
2016 Babu MA, Liau LM, Spinner RJ, Meyer FB. 325 Maintenance of Certification and the Aging Neurosurgeon. Neurosurgery. 63: 194-195. PMID 28175478 DOI: 10.1227/01.neu.0000489814.98347.ee  0.01
2015 Liau LCK, Lin YG. Fabrication of assembled ZnO/TiO2 heterojunction thin film transistors using solution processing technique Solid-State Electronics. 103: 54-58. DOI: 10.1016/j.sse.2014.09.006  0.01
2014 Liau LCK, Hsu TH, Lo PH. Characterizing p-channel thin film transistors using ZnO/hydrated polyvinyl alcohol as the conducting channel Applied Physics Letters. 105. DOI: 10.1063/1.4893450  0.01
2011 Liau LCK, Lin CY. Vacancy defect distribution of colloidal particle deposition in a sedimentation process investigated using Kinetic Monte Carlo simulation Colloids and Surfaces a: Physicochemical and Engineering Aspects. 388: 70-76. DOI: 10.1016/j.colsurfa.2011.08.012  0.01
2011 Liau LCK, Ma CK. Investigation of Electronic Properties for Nano-Titania/Metal-Ion-Doped Titania Semiconductor Prepared by Sol-Gel Methods Supplemental Proceedings: General Paper Selections. 3: 1-9. DOI: 10.1002/9781118062173.ch1  0.01
2011 Liau LCK, Ma CK. Investigation of electronic properties for nano-tatania/metal-ion-doped semiconductor prepared by sol-gel methods Tms Annual Meeting. 3: 3-9.  0.01
2009 Liau LM. Comments Neurosurgery. 64: 835. DOI: 10.1227/01.NEU.0000343525.89321.C5  0.01
2009 Liau LCK, Chou WW. Fabrication of field-effect transistors based on Fe3+-doped titania by sol-gel methods Semiconductor Science and Technology. 24. DOI: 10.1088/0268-1242/24/5/055007  0.01
2009 Liau LCK, Chou WW. Investigation of field-effect transistors fabricated by metal-ion-doped nano-titania using sol-gel technique Microelectronic Engineering. 86: 361-366. DOI: 10.1016/j.mee.2008.11.013  0.01
2008 Liau LM. An account of the life and achievements of Miss Diana Beck, neurosurgeon (1902-1956): Commentary Neurosurgery. 62: 741. DOI: 10.1227/01.Neu.0000317324.71483.E5  0.01
2008 Liau LCK, Chou WW, Wu RK. Photocatalytic lithography processing via poly(vinyl butyral)/TiO 2 photoresists by ultraviolet (UV) exposure Industrial and Engineering Chemistry Research. 47: 2273-2278. DOI: 10.1021/ie071331o  0.01
2008 Liau LM. Commentary Surgical Neurology. 70: 266-267. DOI: 10.1016/j.surneu.2007.07.041  0.01
2008 Liau LCK, Chen CC. Optimal heating trajectories of controlling green tapes of YSZ electrolyte deformation using TMA during thermal processing Journal of Power Sources. 177: 1-8. DOI: 10.1016/j.jpowsour.2007.11.041  0.01
2008 Liau LCK, Huang YK. Process optimization of sedimentation self-assembly of opal photonic crystals under relative humidity-controlled environments Expert Systems With Applications. 35: 887-893. DOI: 10.1016/j.eswa.2007.07.051  0.01
2008 Liau LCK, Dai WW. Process optimization of preparing spherical titania colloids with uniform distribution using artificial neural networks Colloids and Surfaces a: Physicochemical and Engineering Aspects. 320: 68-73. DOI: 10.1016/j.colsurfa.2008.01.014  0.01
2008 Liau LCK, Huang YK. Effects of influential factors on sedimentation self-assembly processing of photonic band gap crystals by relative humidity-controlled environments Chemical Engineering and Processing: Process Intensification. 47: 1578-1584. DOI: 10.1016/j.cep.2007.07.007  0.01
2008 Liau LM, Cavenee WK. Editors' message to the readership Journal of Neuro-Oncology. 86: 1. DOI: 10.1007/s11060-007-9481-5  0.01
2007 Liau LCK, Lin CC. Fabrication and characterization of Fe3+-doped titania semiconductor electrodes with p-n homojunction devices Applied Surface Science. 253: 8798-8801. DOI: 10.1016/j.apsusc.2007.04.077  0.01
2007 Liau LCK, Chiang PI. Multiple nano-TiO2 layers to prevent dye/nano-TiO2 from photodegradation under a UV-exposure environment Applied Surface Science. 253: 3982-3986. DOI: 10.1016/j.apsusc.2006.08.031  0.01
Hide low-probability matches.